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Detoxification and homeostatic acquisition of metal ions are vital for all living
organisms. Non-physiological heavy metals are toxic at low concentrations and represent
major environmental hazards to human health. In particular, cadmium is a toxic
environmental pollutant linked to a number of ailments including cancer, kidney and
bone disease and reproductive disorders. The biological effects of cadmium toxicity
which lead to human disease and the cellular mechanisms for cadmium defense are ill
defined. Thus, the study of heavy metal detoxification systems represents an important
research avenue to help combat cadmium related disorders.
The goal of this research project was to identify novel factors involved in metal
ion defense in the model eukaryote, Saccharomyces cerevisiae. A genetic screen led to
the discovery of Pca1, a P-type ATPase which functions as a cadmium-specific efflux
pump. Unexpectedly, the PCA1 allele in common laboratory yeast strains possesses an
inactivating mis-sense mutation which has complicated previous attempts to characterize
its function.
A unique feature of Pca1 is a cysteine-rich cytosolic amino terminal extension
that can participate in metal coordination and regulate expression levels. Under normal
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conditions, Pca1 is an unstable protein that is ubiquitinated and rapidly degraded by the
proteasome. However, in the presence of cadmium, ubiquitination is inhibited resulting in
rapid up-regulation and trafficking of Pca1 to the cell surface for cadmium efflux. An
autonomous degradation signal within the cysteine-rich domain is necessary and
sufficient for metal responsive regulation.
Finally, a second genetic screen was devised to uncover factors involved in Pca1
degradation. Unexpectedly, components of the ER-associated degradation (ERAD)
pathway were found to be required for Pca1 turnover in the absence of cadmium.
Conformational changes associated with cadmium binding to the metal sensing
degradation signal lead to the escape of Pca1 from ERAD.
In summary, our data have revealed a novel metal detoxification system in a
eukaryotic organism mediated by a P-type ATPase that is unique in structure and
substrate specificity. Furthermore, we have described an unprecedented mode of ligand
regulated degradation of a cell surface transporter at the ER and have provided the
mechanistic basis of this regulation.
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Introduction
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1.1.

Cadmium, a Toxic Heavy Metal
1.1.1. Physical Properties. Cadmium is a non-physiological heavy metal that is

one of the most serious environmental pollutants. The only known example of a
biological function for cadmium has been described for the marine diatom Thalassiosira
weissflogii in which cadmium can replace the zinc cofactor in carbonic anhydrase II
when cells are growing under extreme zinc deficiency (1). Zinc and cadmium belong to
the same column on the periodic table (2B) with filled 3d and 4d orbitals and
consequently they share many physical properties. Cadmium (II) is the only accessible
reduction state following the loss of two 5s electrons under physiological conditions.
Thus cadmium is not a redox active metal and does not initiate Fenton reactions directly.
Cadmium is classified as a soft Lewis acid and has a very high affinity for easily oxidized
ligands, such as oxygen and sulfur. Cadmium is then expected to displace zinc from
protein ligands containing a sulfur dominated coordination sphere. Cadmium occurrence
is mainly associated with other heavy metals including zinc, and to a lesser extent copper
and lead thus cadmium is an inescapable by-product of metallurgy. The chemical
properties of cadmium have been implemented into a wide range of technical applications
that include nickel-cadmium batteries, pigments, and various metal alloys just to name a
few.
1.1.2. Human Exposure to Cadmium. It is estimated that up to 30,000 tons of
cadmium are released into the environment each year where one-half is liberated by
weathering rocks and the other half is produced by industrial activities (2). The
manufacturing and disposal of cadmium-containing compounds has led to a significant
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increase of cadmium exposure to humans. Approximately 512,000 employees in the
United States work in environments which potentially expose them to cadmium (2). Air
pollution can also arise from non-human processes such as wind blown cadmium powder
suspensions at the surface of the earth or dispersion of volcanic gases. Cadmium released
into the environment ultimately enters the food chain and water supply. Agricultural
activities contribute to the incorporation of cadmium from soil and minerals into crops
which are used for human consumption. The cadmium content in soil determines metal
accumulation in plants which is influenced by natural geological features or industrial
pollution. Cadmium concentrations in plants typically range from 0.5 - 5µM but can
reach more than 100µM in hyper-metal-accumulating plants (3). Use of fertilizers greatly
increases soil cadmium concentrations and acidification enhances solubility and uptake
into plants (3). The greatest risk for cadmium exposure occurs through cigarette smoke.
One cigarette contains about 1-2µg of cadmium of which 10% is inhaled into the lungs
while smoking. While only a small percentage of cadmium is absorbed in the digestive
tract, up to 50% of inhaled cadmium enters the blood stream (4). Under conditions of iron
deficiency such as in a low iron diet and pregnancy, cadmium uptake is increased due to
up-regulation of iron transporters which exhibit broad substrate specificity (4).
1.1.3. Toxic Cellular Effects and Pathologies of Cadmium Exposure. The
toxic effects of cadmium on cellular functions are multifarious. The deleterious effects of
cadmium are believed to stem from its ability to replace essential metal cofactors in
metalloenzymes and binding to thiol-containing proteins involved in oxidative stress
defense (e.g., glutathione, thioredoxin and thioredoxin reductase). Consequences include
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changes in gene expression, cell cycle progression, proliferation, differentiation, signal
transduction, inhibition of DNA replication and repair, induced apoptosis, endocrine
disruption and alterations of metal and redox homeostasis (5).
The human clinical symptoms of cadmium poisoning are correlated to the organ
distribution of the metal. Emphysema and chronic rhinitis have been linked to cadmium
inhalation. Cadmium is classified as a class I pulmonary carcinogen because of the high
incidence of lung cancer of individuals who were occupationally exposed to cadmium
(4). Cadmium is likely responsible for the onset of other cancers but the scarcity of data
has not extended the range of carcinogenicity beyond lung carcinoma. One of the main
target organs of cadmium toxicity is the kidney. Renal tubular damage is an adverse
effect resulting from chronic cadmium exposure (4,6,7). Renal damage results in
inadequate activation of vitamin D which leads to decreased calcium absorption and
impaired bone mineralization.

Bone disease associated with prolonged cadmium

exposure was first reported in a cadmium contaminated river basin in Japan where
several cases of Itai-Itai disease were recognized (4).
Cadmium has also been associated with reproductive and developmental defects.
Cadmium exposure during pregnancy is correlated with an increased incidence of low
birth weight and spontaneous abortion (4). Cadmium affects steroid synthesis pathways
and secretion of progesterone, a hormone that plays a critical role in maintaining
pregnancy (8). In mammals the estrogenic effects of cadmium induce uterine hyperplasia,
mammary gland development, early onset of puberty, male infertility and breast cancer
(9,10). Alarmingly, the doses of cadmium which exhibited estrogenic effects were similar

5
to human dietary exposure. Moreover, cadmium could exhibit synergistic estrogenic
effects in combination with dietary phytoestrogens (9).
1.1.4. Cadmium Absorption. Cadmium is a non-essential metal and is unlikely
to enter cells through a transport mechanism specific for cadmium. Cadmium particles
breathed in through the nose move through the primary olfactory neurons to their final
destination in the olfactory bulb. In the lungs, cadmium can pass through alveolar cells
directly into the bloodstream despite an efficient barrier in the lung epithelium for other
toxic molecules and heavy metals (11). The mechanism by which cadmium reaches
circulation is not well characterized but likely involves uptake through channels or
transporters dedicated for essential ions or other biomolecules (Figure 1.1). Ingested
cadmium enters the digestive tract where the acidic environment favors absorption at the
apical membrane of enterocytes. The proton-metal Iron(II) cotransporter, DMT1 (DCT1,
Nramp2), appears to be involved in this process (11). Zinc transporters have also been
implicated in cadmium uptake. The putative mouse zinc transporter ZIP8 has been
attributed with cadmium uptake in vascular epithelial cells of testis (12). Moreover,
deletion or overexpression of Zrt1, a plasma membrane zinc transporter in yeast
Saccharomyces cerevisiae, affects cadmium uptake (13). There is also evidence that
cadmium may permeate cells through calcium channels (14-16). Cadmium uptake may
also occur by other mechanisms which may include endocytosis of Cadmium-bound
molecules, organic cation transporters (OCT) or transporters of other metal ions such as
manganese (17) .
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1.1.5. Subcellular Distribution and Sequestration. Once inside the cell,
cadmium is sequestered by metallothionine (MT), a cysteine-rich peptide, as well as
glutathione (GSH) (Figure 1.1). In eukaryotes this is thought to be the first line of
defense for neutralizing cadmium and other toxic heavy metals (18-22). In S. cerevisiae,
GSH-conjugated cadmium is compartmentalized into the vacuole by the ATP-binding
cassette (ABC) transporter, Ycf1 (23). In plants and fission yeast Schizosaccharomyces
pombe, cadmium is sequestered by phytochelatin, a GSH polymer (20). It is possible that
other unidentified cadmium-binding proteins or molecules may exist as has been
demonstrated for other heavy metals. For example, cytosolic metallochaperones deliver
copper, a vital yet toxic trace element, as a cofactor to copper-requiring proteins through
direct protein-protein interactions. This strategy ensures that there is virtually no unbound
copper in the cytoplasm where it can catalyze unwanted Fenton and Haber-Wiess
reactions (24). Recently, an iron-binding protein was discovered that ferries iron to its
storage protein, ferritin (25). In E. coli, arsenic, a toxic non-physiological metalloid, is
delivered to an efflux pump by a cytoplasmic protein (26). Thus, intracellular trafficking
of cadmium may be a carrier mediated process.
1.1.6. Cadmium Extrusion. In prokaryotes, a plethora of metal efflux pumps,
including P-type ATPases, ATP binding cassette (ABC) transporters, resistancenodulation-cell division transporters (RND) and cation diffusion facilitators (CDF), have
all been described (27-29). In Gram-Positive bacteria cadmium extrusion is mediated
through the P1B-type ATPase, CadA (30). Aside from known bacterial metal efflux
systems, the mechanisms of cadmium efflux in eukaryotes remain largely unknown.

7
Recently, the yeast ABC transporter, Yor1, has been proposed to efflux GSH-conjugated
cadmium out of the cell (31). In plants, several P-type ATPases which resemble the
bacterial divalent (zinc(II)/cobalt(II)/cadmium(II)/lead(II)) cation transporters and an
ABC transporter have been implicated in cellular cadmium efflux (32-34). In humans,
the excretion rate of cadmium is relatively low (35). The long residence time in the body
likely reflects the high affinity of cadmium for sulfhydryl groups of cellular ligands and
the lack of an efficient excretion system. Mammalian studies have suggested that
multidrug resistance proteins (MRP’s) could transport GSH or cysteine conjugated
cadmium out of hepatocytes and renal epithelial cells (36,37). Further characterization of
cadmium extrusion systems will ultimately enhance our ability to combat cadmium
related disorders.
1.1.7. Protective Cellular Responses to Cadmium. Cells regulate a number of
biochemical pathways to protect themselves from cadmium toxicity. In mammals, both
GSH and MT gene transcription are induced by the MTF-1 transcription factor in
response to cadmium and oxidative stress (22,38). In S. cerevisiae, copper sensing by the
Ace1 transcription factor induces MT production (39), however cadmium induction of
MT is strain specific and the transcription factor responsible is unknown (40). Cadmium
up-regulates GSH and other antioxidant enzymes (superoxide dismutase, thioredoxin and
thioredoxin reductase) by thiol dependent activation of the Yap1 stress response regulator
(41). Remarkably, sulfur metabolism in both yeast and mammals can be reorganized in
response to cadmium resulting in a significant increase in GSH production. This
restructuring of transcriptional circuitry is accomplished by cadmium induced
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inactivation of S. cerevisiae Met4 and mammalian Nrf2 or the ubiquitination and
proteasomal degradation of S. pombe, Zip1 transcription factor (42). Cadmium also
modifies expression levels of other stress responsive proteins such as heat shock proteins
(HSPs). HSPs play an important role in protein folding and in the degradation of
damaged or mis-folded proteins. Induction of HSPs is most likely a response to
cadmium-mediated denaturation and/or oxidative damage of proteins. Cells can also
protect themselves by curbing cadmium uptake. In S. cerevisiae, zinc, cobalt or cadmium
can trigger the degradation of the ZRT1 zinc transporter preventing excessive metal
uptake (43). The evolution of these diverse cellular responses underscores the
significance of cellular defense against cadmium toxicity.

Figure 1.1. A model of Cd metabolism in yeast S. cerevisiae and mammals.
Divalent nutritional metal transporters mediate Cd uptake across the plasma
membrane. Intracellular glutathione (GSH) and metallothionine (MT) play critical
roles in Cd chelation. In yeast, Ycf1 sequesters GSH-conjugated Cd into the
vacuole. Cd induces detoxification pathways through several mechanisms, including
enhanced gene expression by Yap1, Ace1, Met4 in yeast and MTF1 and Mrf2 in
mammals. Cadmium extrusion factors are largely unknown.
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1.2.

P1B-Type ATPases
1.2.1. Function and Classification. P-type ATPases are an important family of

active membrane transporters that play fundamental roles in cell function by maintaining
ion gradients. They are ubiquitous and are involved in transport processes in virtually all
living organisms. P-type pumps are required for nutrient uptake, muscle contraction,
neurotransmission, signaling and excretion of toxic heavy metals (29,32,33,44-48). Ptype ATPases are categorized into 5 main groups (Types I-V) based on sequence
homology. Within these branches several subtypes or classes can be distinguished based
on substrate specificity. For instance, the P1B class transports “soft” transition metals
copper(I), silver(I) copper(II), zinc(II), lead(II), mercury(II), cobalt(II) and cadmium(II)).
P1B ATPases are found in almost all organisms ranging from bacteria to humans. Based
on substrate specificities, they are further divided into monovalent and divalent
translocating ATPases (49). P1B ATPases are vital for metal detoxification in bacteria
(29). In eukaryotes copper translocating ATPases are linked to two human genetic
diseases, Wilson and Menkes disease. Consequently, because of their medical relevance,
these copper pumps have received much attention regarding their mechanism of action
and regulation. Cloning of the genes that are defective in Wilson and Menkes disease
revealed that two P1B-type ATPases, ATP7a (MNK) and ATP7b (WND) are essential for
copper acquisition and excretion in humans. Yeast S. cerevisiae also possesses a
homologue of WND and MNK (50). The pathogenic yeast, C. albicans, expresses an
additional copper efflux ATPase (CaCRP) at the plasma membrane which leads to high
copper tolerance (51). Plants contain several P1B-type ATPases (eight in A. thaliana) that
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appear to be involved in subcelluar distribution and tissue compartmentalization of metal
ions (32,33).
1.2.2. Structure and Mechanism of Action. Crystal structures have been solved
for Type III ATPases (Ca2+-ATPase and Na+,K+-ATPase) and a Type II ATPase (H+ATPase). However, little is known about the structure and mechanism of action of metal
transporting PIB-type ATPases which are structurally distinct from Type II and III P-type
ATPases. P1B ATPases are composed of three principle domains, an ATP-binding domain
(N domain), a phosphorylation domain (P domain), and an actuator domain (A domain)
(44) (Figure 1.2.). Unlike other P-type ATPase family members, P1B-type ATPases
possess 8 transmembrane domains, a CPX or SPC motif at the 6th transmembrane helix,
and metal binding domains (MBDs) at the N and/or C terminus. Structures of these
domains have been solved separately. However, a complete structure of a full length
P1B-type ATPase is yet to be solved.

Figure 1.2. Schematic depiction of P1B-type ATPase Conserved Features. Eight
transmembrane helixes, metal binding domains (M) containing GMXCXXC motif,
CPX motif within 6th transmembrane helix, an actuator domain (A), a
phosphorylation domain (P), and a nucleotide binding domain (N) are indicated.
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The postulated mechanism of ion translocation of P1B-type ATPases is based on
the Post-Albers cycle for the Na+/K+ ATPase (45) (Figure 1.3.). Cytosolic ATP and metal
ions bind to the E2 state, which converts the enzyme to the E1 form. Conformational
changes resulting from ATP phosphorylation and dephosphorylation drive metal ion
translocation across the membrane. After releasing Pi, the enzyme is converted to the E2
form to initiate the next cycle. It is not known yet how many metal ions are translocated
per cycle and whether there is counter translocation of ion(s) from the other side of the
membrane

Figure 1.3. P1B-Type ATPase catalytic cycle. E1, E2, E1P and E2P represent the
conformations based on the Post-Albers model for the Na+-K+ ATPase. Mn+
represents a metal transported by the enzymes. “n” indicates the uncertainty on the
specific stoichiometry of transport. Mn+cyt and Mn+out represent the cytoplasmic or
extracellular/luminal localization of the transported metals. Figure adapted from
(49)
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The CPX/SPC motif at the 6th transmembrane helix is thought to coordinate metal
ions during translocation. Sequence alignments and site-directed mutagenesis have
predicted other potential metal binding residues located in the 7th and 8th trans-membrane
domains as well (49,52). However, metal coordination during transport and the
mechanisms of P1B-type ATPases remain to be determined. Moreover, the molecular
determinant(s) that define substrate specificity are not known.
Most P1B-type ATPases possess N and/or C-terminal MBDs that are believed to
play roles in catalysis and/or regulation (52). The human Cu+ transporting ATPases,
WND and MNK, possess 6 MBDs (~70 amino acids, βαββαβ fold) at the N-terminus
(53,54). This domain is conserved in many P1B-type ATPases, and the number of repeats
can vary. Several atypical MBDs have also been identified (55,56). The conserved MBD
contains a GMXCXXC motif in which two cysteine residues coordinate a single Cu+ ion
(53,54) . The Atx1 metallochaperone delivers copper(I) to these domains through direct
docking to the 2nd and 4th domains of WND, suggesting distinct functions of these
domains (57,58). Despite structural and metal binding properties have been well
characterized, their roles in ATPase function are not clear yet. Copper binding was
initially proposed as a substrate recognition step followed by transfer of copper(I) to the
translocation pore. Consistently, several disease causing mutations within WND have
been mapped to Atx1 binding sites (59,60). However, site-directed mutagenesis and
deletion of MBDs also suggest a regulatory role for these domains in the catalytic
activities of P1B-type ATPases. Recently, it was proposed that the metallochaperone can
transfer a metal substrate directly to the trans-membrane metal-binding site for
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translocation (61). Collectively, while significant progress has been made in the metal
binding properties of MBDs, their functional roles in activity and/or regulation of P1Btype ATPases remain elusive.
1.2.3. Regulation. Several modes of regulation control expression levels,
subcelluar localization, and activities of P1B-type ATPases. Transcriptional control in
response to metal ions appears to be a major regulatory mechanism in bacteria and plants
(29,32,33,45).

However, in mammals metal mediated regulation of Copper(I)-

transporting P1B-type ATPases mainly relies on alterations of their subcelluar trafficking
(59,62-65). In a low copper medium, the human MNK and WND proteins are localized
to the trans-Golgi network where they transport copper for incorporation into secretory
proteins. When copper levels are elevated, MNK is mobilized to the plasma membrane in
a reversible manner. The biological significance of this trafficking event is that MNK
participates in copper extrusion to protect cells from toxicity. In the liver, excess copper
mobilizes WND from the trans-Golgi network to a cytoplasmic vesicle-like compartment
associated with the canicular membrane of bile ducts. The biological significance appears
to be an important mechanism for excretion of excess copper into bile to maintain
systemic copper homeostasis. However, it is not known exactly what molecular changes
(e.g. conformational change, phosphorylation, disulfide bond formation, and/or
interaction with other proteins) trigger trafficking of MNK and WND in response to
copper.
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1.3. Subcellular Trafficking of Membrane Proteins in Yeast
Membrane proteins including P1B-type ATPases traffic through the secretory
pathway to their final destination. In S. cerevisiae, as many as 282 membrane solute
transporters have been identified of which a minimum of 125 reside at the cell surface
(66). A number of these transporters have been reported to be subject to strict regulation
in context of their trafficking and degradation according to environmental conditions.
Many of the same principles which govern the regulation of transporters appear to be
conserved in plants and animals making yeast a powerful system for dissecting these
mechanisms in detail.
1.3.1. Folding, Maturation and Assembly at the Endoplasmic Reticulum.
The endoplasmic reticulum (ER) is the gateway for entry into the secretory pathway.
Newly synthesized membrane proteins are cotranslationally integrated into the ER
through a narrow cytosolic channel formed by the heterotrimeric Sec61p complex. Most
transmembrane proteins do not possess a cleavable signal sequence but instead are
targeted to the ER by the first hydrophobic segment which functions as an internal signal
sequence (67). Translocation is halted by hydrophobic stop-transfer segments within the
primary amino acid sequence where charged residues flanking the hydrophobic segment
are believed to determine the orientation of the segment across the membrane (68).
During or after translocation protein folding is assisted by various chaperones. In some
instances proteins acquire N-linked glycosylation, disulfide bond formation or must
oligomerize into higher order structures before being deemed fully mature (69). Correct
protein folding and assembly is often inefficient and can be hindered by genetic error and
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cellular stress. The accumulation of unfolded proteins induces the unfolded protein
response (UPR) pathway which alleviates ER stress by inhibiting protein translation and
up-regulating protein folding and degradation pathways (70) .
1.3.2. ER to Golgi Trafficking. After passing all quality control checkpoints,
proteins are packaged into transport vesicles destined for the Golgi prior to sorting into
the secretory pathway.

Intracellular sorting between compartments requires vesicle

carriers that are released from a donor to an acceptor compartment following vesicle
fusion (71). Correctly folded and assembled cargo proteins are packaged into COPIIcoated vesicles and are transferred to the Golgi network. For some cargo proteins,
packaging requires a diacidic motif which is recognized by the COPII protein, Sec24
(72). Cargo receptors and components of the membrane fusion machinery are returned to
the ER by COPI coated vesicles (Figure 1.4.).
1.3.3. Golgi to Plasma Membrane Trafficking. The mechanism of cell surface
targeting of plasma membrane proteins is largely unknown. Once at the Golgi apparatus
membrane proteins are sorted to the plasma membrane or other secretory compartments
via secretory vesicles (SV). At least two different routes, involving vesicle populations of
different densities, low-density secretory vesicles (LDSV) or high density secretory
vesicles (HDSV) carry distinct exocytic cargo en route to the plasma membrane (73).
Association with membrane lipid rafts is required for proper trafficking of some
membrane proteins to the plasma membrane (74).
1.3.4. Ubiquitin Dependent Endocytosis and Vacuolar Degradation. Proteins
are often marked for degradation by post-translational conjugation to ubiquitin, a 76
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amino acid protein that is conserved from yeast to humans (75). The first step in
ubiquitination is the activation of the C-terminal α carboxyl group of ubiquitin by ATP
resulting in an adenyl intermediate followed by the subsequent formation of a thiol ester
bond with a cysteine of an (E1) ubiquitin-activating enzyme. Ubiquitin is then transferred
to a cysteine of a ubiquitin-conjugating enzyme (E2). Ubiquitin loaded E2s bind
specifically to ubiquitin ligases (E3) that bind directly to protein substrates. The E3s
themselves can be conjugated with ubiquitin through a thioester bond before substrate
attachment, or act as a bridge between the activated E2 and its substrate. Ubiquitin is
usually attached through an isopeptide bond to the ε-amino group of a lysine residue of
the substrate.
Several cell surface transporters are down-regulated by ubiquitin-dependent
endocytosis followed by vacuolar targeting via endosomal compartments. A key factor in
this process is the ubiquitin E3 ligase Rsp5 along with other adaptor proteins which can
mediate client specific ubiquitination of substrates (76).
The ubiquitin moiety acts as an internalization signal which is recognized by
ubiquitin binding proteins that contain variable effector domains which recruit clathrin
proteins that function in membrane bending and invagination. Internalization is also
thought to require correct organization of the actin cytoskeleton as several transporters
accumulate as ubiquitin conjugates in mutants impaired in cytoskeleton formation (77).
Following vesicle budding and internalization, ubiquitinated cargos are transported into
endocytic compartments called early endosomes (EE). At this holding station, endocytic
vesicles can be recycled back to the plasma membrane or can fuse with the limiting
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Figure 1.4. Trafficking of membrane proteins in yeast. Correctly folded and
assembled cargo proteins are packaged into COPII-coated vesicles and are
transported to the Golgi network. Terminally misfolded proteins (*) are
retranslocated to the cytosol for proteasome dependent degradation. COPI proteins
induce formation of return vesicles that retrieve cargo receptors and components of
membrane fusion machinery to the ER. Cell surface proteins are transported from
the trans-Golgi network to the plasma membrane (PM) via secretory vesicles (SV).
Ubiquitin dependent endocytosis targets some plasma membrane proteins to the
early endosome (EE). Internalized substrates can be recycled back to the plasma
membrane or can proceed to late endosomes/multivesiclar body (LE/MVB) where
ubiquitinated cargo is internalized into vesicles. Fusion of the mature LE/MVB with
the vacuole delivers internalized contents for vacuolar degradation. Under certain
conditions some plasma membrane proteins are directly sorted to the vacuole for
degradation.
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membrane of the late endosome/multivesiclar body (LE/MVB). At the limiting
membrane of the LE/MVB ubiquitinated substrates are internalized into vesicles.
Subsequent fusion with the vacuole delivers the internal vesicles carrying ubiquitinated
cargos into the vacuolar lumen for degradation by vacuolar proteases and lipases. This
process allows for discrimination in the sorting of proteins to the vacuole limiting
membrane or to the lumen of this organelle for degradation. In some instances, newly
synthesized membrane proteins are ubiquitinated at the Golgi where they are diverted
directly to the vacuole for degradation without ever reaching the plasma membrane
(Figure 1.4.).
1.3.5. Physiological Regulation of Transporter Trafficking. Organisms must
meet the demands of changing conditions within the environment. Several nutritional
transporters are down-regulated by targeting to the vacuolar degradation pathway in
response to specific stimuli. The general amino acid permease, Gap1, is active under
conditions of limiting nitrogen supply. Under these conditions the GAP1 gene is
transcribed and newly synthesized protein is targeted directly to the plasma membrane.
When a preferred nitrogen source is available, such as ammonia, the GAP1 gene is
repressed and pre-synthesized Gap1 is rapidly removed from the plasma membrane
through ubiquitin dependent endocytosis and is sorted into the MVB/vacuolar pathway
for degradation (78). When cells are grown with glutamate as the sole nitrogen source,
newly synthesized Gap1 is ubiquitinated by Rsp5 and is directly targeted to the
MVB/vacuolar pathway without ever reaching the plasma membrane (79).
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Metal transporters are also tightly regulated due to the requirement of nutritional
metals at specific concentrations which is critical to avoid potential toxicity. Zrt1, a highaffinity Zn transporter, is rapidly internalized by Rsp5-dependent ubiquitination within
minutes of exposure to high Zn levels to prevent toxicity (43). The Mn transporters, Smf1
and Smf2, are targeted to the vacuole by Rsp5 dependent ubiquitination in response to
excess Mn (80). Interestingly, mutations that abolish Smf1 transport activity affect
trafficking which suggests that conformational states during metal transport are
recognized by the ubiquitination machinery (81).
There is growing evidence that direct substrate binding to transporters plays a
pivotal role in controlling membrane trafficking. The nucleotide transporter Fur4
undergoes Rsp5 dependent ubiquitination and internalization in the presence of excess
uracil. If synthesized in the presence of its uracil substrate, Fur4 undergoes Rps5
mediated ubiquitination at the Golgi and is directly sorted to the vacuolar degradation
pathway (82,83). A Fur4 mutant, which has a very low affinity for uracil, circumvents
vacuolar sorting and instead localizes to the plasma membrane despite the presence of
intracellular uracil. This observation suggests that binding of uracil to Fur4 leads to
conformational changes that facilitate ubiquitination.
Perhaps the best illustration of trafficking regulation by substrate binding is that
of the Arn1 ferrichrome (FC) transporters. S. cerevisiae can uptake iron bound to
siderophores by two separate systems, one of which requires the ARN family of ironsiderophore transporters. In the absence of its FC substrate Arn1 localizes to endosomelike intracellular vesicles. It has been proposed that low concentrations of endocytosed
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FC substrate a sensed by a high affinity binding site of the Arn1 transporter which
promotes sorting from endosomes to the cell surface for iron-siderophore uptake. While
at the cell surface, excess amounts of FC bind to a low affinity binding site of Arn1,
which induces internalization and targeting to the MVB/vacuolar pathway for
degradation thus preventing excess FC uptake (84,85).
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1.4. Quality Control and Regulated Degradation at the ER. Misfolded proteins which
do not pass ER quality control specifications are transported back across the ER
membrane into the cytosol where they are almost always ubiquitinated before
degradation by the 26S proteasome (86-89). This process has been referred to as ERassociated degradation (ERAD) (90). Inefficiencies in ERAD result in accumulation of
malfolded proteins and cell death leading to various diseases such as diabetes,
inflammation and neurological disorders including Alzheimer’s disease, Parkinson’s
disease and bipolar disorders (91)
1.4.1. Recognition of soluble luminal substrates
Hsp70 chaperones, including mammalian BiP or yeast Kar2, bind exposed residues with
overall hydrophobic character which would be normally buried in a properly folded
protein (68). Hsp70 chaperones bind and release substrates in an ATP dependent manner.
Hsp70s like BiP and its co-chaperones are essential for maintaining solubility of newly
translocated proteins which in turn facilitates proper folding (92). It is then logical that
luminal chaperones are also important for delivery and/or targeting of terminally misfolded proteins for ERAD (93). Indeed Kar2 is required for efficient degradation of
several soluble luminal ERAD substrates in yeast (94).
Instead of binding avidly to hydrophobic peptides, some ER luminal chaperones
known as lectins preferentially interact with distinct sugar residues which are appended to
secretory proteins by ER resident oligosaccharyltransferases (95-97). A core Glc3-Man9GlcNAc2 glycan (where Glc is glucose, Man is mannose and GlcNac is Nacetylglucosamine) is added to asparagine residues. The trimming and re-addition of
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glucose residues act as a folding “timer”. The monoglucosylated species has a high
affinity for calnexin and calreticulin, which are integral membrane and soluble lectins
located in the ER, respectively. Both calnexin and calreticulin interact with ERp57, a
member of the PDI family which forms transient disulfide bonds with calnexin and
calreticulin-bound proteins to assist in folding (98,99). This “timer” is controlled by
mannosidase I, which slowly cleaves the α1,2-linked mannose residue from the middle
branch generating a Man8GlcNAc2 glycan which leads to association with ER
degradation-enhancing 1,2-mannosidase-like protein (EDEM) or Htm1p/Mnl1p in yeast
(100-102). EDEM then diverts misfolded proteins for dislocation into the cytosol and
proteasomal degradation.
1.4.2. Recognition of Integral Membrane ERAD Substrates. Little is known
about how misfolded integral membrane proteins are recognized and sorted into the
ERAD pathway but like luminal substrates this process likely involves the exposure of
hydrophobic residues which are normally buried in a native state. Since the ER
membrane forms a barrier between the ER lumen and the cytosol, misfolded lesions
present in luminal domains or cytosolic domains of integral membrane proteins are
spatially separated and require different recognition factors. Integral membrane substrates
can be classified according to where misfolding occurs within the protein. Integral
membrane proteins with lesions that occur within cytoplasmic domains utilize the
ERAD-C pathway, whereas misfolding that occurs in luminal or transmembrane domains
follow the ERAD-L and ERAD-M pathways, respectively (Figure 1.5.).
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Cytosolic Hsp70 chaperones and Hsp40 co-chaperones have been proposed to
play roles in the recognition of ERAD-C substrates by binding exposed hydrophobic
residues (93). However it is uncertain whether cytoplasmic chaperones maintain protein
solubility by preventing aggregation of exposed hydrophobic residues or whether they
play an active role in substrate recognition and recruitment to the ERAD machinery. ER
resident E3 ubiquitin ligases may also play a role in recognition of ERAD-C substrates.
Integral membrane proteins with luminal lesions utilize many of the same factors
involved in the recognition of misfolded soluble proteins that reside in the ER lumen.
These include luminal Hsp70/40 chaperones (Kar2/Jem1 and Scj1), protein disulfide
isomerase (PDI), and putative carbohydrate binding lectins (Yos9 and Htm1/Mnl1) (93).
Factors involved in the recognition of lesions within the transmembrane domain (ERADM) are largely unknown. It has been proposed that they can be directly recognized by
ER-membrane localized E3 ligases.
1.4.3. Retranslocation. Proteasomal degradation requires retrograde transport out
of the ER to the cytosol. It remains unknown how exactly this occurs. It has been
postulated that retranslocation occurs through Sec61, which is the major component of
the translocation channel that imports polypeptides into the ER (103,104). Nevertheless,
Sec61 cannot be the only retranslocation channel as integral membrane ERAD substrates
are degraded proficiently in sec61 mutants.
In most cases ubiquitination plays an integral part in the retranslocation process
and has been proposed to serve as a molecular ratchet by preventing the polypeptide from
slipping back through the retranslocation channel. Since the catalytic domains of ER
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resident E3 ubiquitin ligases are located in the cytoplasm, luminal ERAD substrates must
be retranslocated to the cytosolic face of the ER prior to ubiquitination. However, for
integral membrane ERAD substrates containing cytosolic domains it is uncertain if
retranslocation precedes ubiquitination.
1.4.4. Ubiquitination of ERAD Substrates. Nearly all ERAD substrates are
polyubiquitinated prior to degradation by the proteasome (88). In S. cerevisiae, the
ubiquitination of ERAD substrates is mediated by two ER resident RING member
ubiquitin E3 ligases, Hrd1 and Doa10 (105) (106). The catalytic RING domains of both
Hrd1 and Doa10 are located on the cytoplasmic face of the ER. Doa10 also resides within
the nuclear envelope where it catalyzes ubiquitination of nuclear substrates (107). Hrd1 is
stabilized by formation of a complex with Hrd3, another ER resident membrane protein.
Hrd3 contains a large luminal domain which is thought to be involved in substrate
sensing of luminal lesions and is required for ERAD of both soluble and polytopic
membrane proteins (108). With the E2 ubiquitin conjugating enzyme, Ubc7 which is
tethered to the ER membrane via Cue1, Hrd1 catalyzes the ubiquitination of ERAD
substrates with membrane or luminal lesions (109). Ubc1, another E2 ubiquitin
conjugating enzyme, has also been implicated in Hrd1 catalyzed ubiquitination of the
mutant vacuolar enzyme, carboxy-peptidase yscY-S255R, commonly known as CPY*
(110). On the other hand, ERAD substrates with cytoplasmic lesions, or unassembled
subunits of oligomeric complexes are ubiquitinated by Doa10. Doa10 dependent
ubiquitination requires the Ubc7/Cue complex and to a lesser extent the tail anchored
Ubc6 (111). One of the best studied Doa10 substrates is a truncated mutant of the Ste6
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ATP-binding cassette (ABC) transporter of the pheromone, alpha factor, denoted as
Ste6*. Normally, wildtype Ste6 is slowly internalized from the cell surface and targeted
for vacuolar degradation by ubiquitin-mediated endocytosis (112), however a truncation
of the Ste6 C-terminal cytosolic tail results in rapid degradation by ERAD with a half-life
of less than 10 min (113).
According to sequence homology, two human Hrd1 homologues (HRD1 and
gp78) and one Doa10 homologue (TEB4) have been identified. The mammalian
homologues of yeast Ubc6 and Ubc7 are MmUbc6 and MmUbc7, respectively. Like
yeast Ubc6, MmUbc6 is anchored to the ER by a C-terminal membrane domain.
However a Cue1 homologue has not been identified in mammals. Instead MmUbc7 is
recruited to the ER by a Cue domain already present within gp78 (114).
1.4.5. Substrate Extraction and Delivery to the Proteasome. Following
ubiquitination, a series of ubiquitin-binding proteins escort modified substrates from the
ER to the proteasome. One of these factors is the AAA ATPase, Cdc48 (p97 in
mammals) which along with its cofactors (Ufd1 and NpI4) is involved in substrate
extraction and escort of ubiquitinated substrates to the proteasome. Cdc48 is recruited to
the ER membrane by the integral membrane protein, Ubx2 (115). The Cdc48 complex
binds oligo-ubiquitinated substrates as well as Ufd2, an E4 multiubiquitination enzyme
which further extends ubiquitin chains to aid in proteasomal recognition (116).
Polyubiquitinated substrates are recognized by the ubiquitin chain receptors, Rad23 and
Dsk2, which also bind Ufd2 in a Cdc48 dependent manner. Rad23 and Dsk2 share
overlapping properties since ERAD defects are only apparent in a Δdsk2 Δrad23 double
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mutant. Png1p, an N-glycanase that discriminates between correctly folded and misfolded glycoproteins is also recruited to the proteasome via Rad23 in order to remove
glycans from glycosylated ERAD substrates prior to proteasomal degradation (117). In
some instances the proteasome itself has been attributed to extraction of substrates from
the ER. The 19S regulatory particle contains six AAA-ATPases that could also provide
the energy for extraction of some ERAD substrates. For example in yeast a mutant of
pro-alpha factor (pαF*) is not ubiquitinated and the 19S regulatory particle is the only
cytosolic factor required for export from the ER in vitro (88). A significant fraction of
proteasomes in the cell are associated with the ER suggesting that extraction and
degradation is a tightly coupled process (118).
1.4.6. Regulation of Protein Expression by the ERAD Pathway. In addition to
performing a strict quality control role, ERAD can be harnessed for regulated degradation
of select proteins in response to cellular signals. While quality control mechanisms
recognize common structural hallmarks of non-native proteins, short target sequences
called degrons can target naturally expressed proteins for degradation. Under certain
conditions, proteins may display degrons that are recognized by the ER quality control
system and are degraded. These can be masked upon signal sensing which allows escape
from ERAD. Degrons which are recognized by the ERAD machinery have been
described for cytosolic, ER resident and secretory proteins in both yeast and mammals.
In yeast ubiquitination of the cytosolic/nuclear localized transcriptional repressor
MATα2 is dependent upon the ER-resident Ubc6 and Ubc7 E2 conjugating enzymes and
the Doa10 E3 ubiquitin ligase (119,120). A transplantable 67 amino acid degradation
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Figure 1.5. Molecular Factors Involved in Yeast ERAD. ERAD-L substrates are
recognized by ER lumenal Hsp70/Hsp40 chaperones (Kar2, Jem1 and Scj1), PDI,
putative lectins (Yos9 and Htm1/Mnl1) and the lumenal domain of Hrd3. ERAD-C
substrates are recognized by cytosolic Hsp70/Hsp40 chaperones (Ssa1, Ydj1 and
Hlj1) and the Doa10 E3 ligase. ERAD-M substrates may be directly recognized by
the Hrd1 E3 ligase. Ubiquitination of ERAD-L and ERAD-M substrates require
Hrd1 while Doa10 is the ubiquitin ligase of ERAD-C substrates. The Ufd2 E4 ligase
may be involved ubiquitin chain extension of some substrates. Extraction and
proteasome delivery of membrane substrates requires the AAA ATPase, Cdc48 and
its Ubx2 membrane anchor. The ubiquitin binding proteins Rad23 and Dsk2 play a
role in proteasomal recruitment. Ubiquitin moieties are removed by a series of deubiquitinating enzymes (DUBs) that may include Rpn1, and/or Otu1. Glycans are
removed from glycosylated substrates by Png1. Red star depicts misfolding or
degradation signals that lead to entry into the ERAD degradation pathway. Figure
adapted from (93).
signal designated Deg1, targets MATα2 for Doa10 ubiquitination and proteasomal
degradation. A ~19 residue determinant within Deg1 appears to be crucial for recognition
and degradation. Deg1 is predicted to form an amphipathic helix in which a hydrophobic
face appears to be the most critical recognition determinant (121). Heterodimerization of
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MATα2 with its binding partner, MATa1 masks the Deg1 signal resulting in its
stabilization.
A series of Doa10 recognized degrons were identified in a selection of genomic
sequences which destabilized the stable cytosolic protein, Ura3 (122). One of these
artificial degrons identified is CL1, a 16 amino acid sequence (ACKNWFSSLSHGVIHL)
also predicted to form an amphipathic helix and like Deg1 requires patches of bulky
hydrophobic residues (123). A similar amphipathic helical structure targets serum and
glucocorticoid-induced kinase 1 (SGK1) to an ER-resident E3 ligase for ubiquitination
and degradation in mammals (124). Together these observations suggest that surface
exposed hydrophobic residues which are normally buried in native proteins can serve as a
recognition motif for ERAD.
In mammals, secretion of the cholesterol and triglyceride carrier protein,
apoliprotein B100 (ApoB) is also regulated by components of ERAD pathway. A
significant portion of newly synthesized ApoB is degraded by both proteasomal and nonproteasomal pathways, which are regulated by metabolic factors. When conditions are
not favorable for ApoB assembly with lipids, ApoB is ubiquitinated and degraded by the
proteasome (125). This process is facilitated by cytosolic chaperones of the hsp70 and
hsp90 class during ER translocation (125). It has been proposed that ApoB is targeted to
the ERAD machinery co-translationally while still bound to the ribosome. In this model
efficient translocation of ApoB into the ER lumen is dependent on microsomal
triglyceride transfer protein (MTP) dependent lipid transfer to the nascent polypeptide
(126). The stalling of translocation leads to prolonged exposure of hydrophobic domains
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within ApoB to the cytosol for recognition by components of the Ub-proteasome
pathway.
The ER resident HMG-CoA reductase (HMGR) is the rate limiting enzyme of the
mevalonate pathway by which cholesterol and a variety of isoprenoids are synthesized.
The degradation of HMGR and its yeast homologue, Hmg2, are physiologically regulated
by sterols (127-130). When sterol flux is high, HMGR is targeted for ERAD in order to
decrease enzyme levels. When flux is low, HMGR circumvents ERAD, and enzyme
levels increase. Hrd1 (HMG-CoA reductase degradation) with its E2 partners Ubc1 and
Ubc7 mediate the ubiquitination and degradation of Hmg2 in yeast (131,132). Gp78, the
mammalian orthologue of Hrd1 was later identified as the ubiquitin ligase of HMGR
(133). It is not surprising that ER resident proteins like HMGR/Hmg2 are degraded by
ERAD machinery that also resides in the ER. The molecular signal for yeast Hmg2
degradation is derived from farnesyl pyrophosphate (FPP), an intermediate in the
mevalonic acid pathway. In the presence of FPP, Hmg2 acquires structural features of a
misfolded protein as indicated by increased susceptibility to proteolysis which is reversed
by chemical chaperones such as glycerol (134). The N-terminal transmembrane domain
of Hmg2 is both necessary and sufficient for sterol mediated regulation and fusion of this
domain can impart regulation of other stable proteins (135). The details regarding the
nature of the recognition signal within Hmg2 are not known but mapping studies have
uncovered a distributed degron where structural information required for recognition is
dispersed throughout the first N-terminal transmembrane domain (135). More recently,
two yeast ER membrane anchored chaperone proteins, NSG1 and NSG2 were shown to
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be involved in the stabilization of Hmg2 through interaction with the sterol sensing Nterminal domain (136). Further studies of the human orthologue, Insig-1, demonstrated
that sterol induced binding of Insig-1 to the sterol sensing domain of HGMR, leads to
recruitment to the ubiquitin ligase, gp78 (133). Thus, it appears that other adaptor
proteins can contribute to the specificity of ER resident ubiquitin ligases.
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A Cadmium-transporting P1B-type ATPase in Yeast
Saccharomyces cerevisiae
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2.1. Abstract
Detoxification and homeostatic acquisition of metal ions are vital for all living
organisms. We have identified PCA1 in yeast S. cerevisiae as an overexpression
suppressor of Cu toxicity. PCA1 possesses signatures of a P1B-type heavy metal
transporting ATPase which is widely distributed from bacteria to humans. Cu resistance
conferred by PCA1 is not dependent on catalytic activity, but it appears that a cysteinerich region located in the amino-terminus sequesters Cu. Unexpectedly, when compared
to two independent natural isolates and an industrial S. cerevisiae strain, the PCA1 allele
of common laboratory strains we have examined possesses a missense mutation in a
predicted ATP-binding residue conserved in P1B-type ATPases. Consistent to a previous
report which identifies an equivalent mutation in a Cu transporting P1B-type ATPase of a
Wilson disease patient, the PCA1 allele found in laboratory yeast strains is nonfunctional. Overexpression or deletion of the functional allele in yeast demonstrates that
PCA1 is a Cd efflux pump. Cd as well as Cu and Ag, but not other metals examined,
dramatically increase PCA1 protein expression through post-transcriptional regulation
and promote subcellular localization to the plasma membrane. Our study has revealed a
novel metal detoxification mechanism in yeast mediated by a P1B-type ATPase that is
unique in structure, substrate specificity and mode of regulation.
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2.2. Introduction.
Excretion and detoxification of non-physiological metals, homeostatic absorption and
utilization of nutritional yet toxic metals are fundamental biological processes. Metal
toxicity and deficiency resulting from defects in metabolism and excess accumulation
through environmental contamination are implicated in a number of disorders, including
failure in normal growth and development, and initiation and progression of degenerative
diseases (1-7). For instance, a genetic defect in copper (Cu) excretion in the liver leads to
Wilson disease exhibiting hepatic failure and neuronal dysfunctions (7). Cadmium (Cd) is
a well-known industrial and environmental pollutant implicated in cancer, neurological
disorders, reproductive defects, and endocrine disruption (8-12). Cd exerts its toxic
effects by the perturbation of cellular redox balance, inhibition of DNA repair, disruption
of metal ion homeostasis, and alterations in signal transduction (8-12). Mechanistic
insights into metal metabolism in living organisms would facilitate prevention and
treatment of metal-related disorders and to develop methods for efficient remediation of
toxic metals from the environment.
Organisms have evolved defense mechanisms to combat the toxic effects of heavy
metal ions. The P1B-type ATPase family of heavy metal transporters that are distributed
from bacteria to humans extrude toxic metal ions such as Cu, Ag, Zn, Co, Pb and/or Cd
from the cell (13-18). Functional characterization of this family of transporters has
supported the conclusion that efflux mechanisms play critical roles in metal
detoxification in bacterial cells (13-15). Cu-specific P1B-type ATPases have been
identified in eukaryotes as well (2,7,16,17). Cloning of genes defective in Menkes and
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Wilson disease have revealed that two P1B-type ATPases (ATP7a and ATP7b) play
essential roles in Cu acquisition and excretion in humans (2,7,16). Plants express Cu, Zn,
Co, Pb and/or Cd-translocating ATPases that appear to be involved in distribution and
compartmentalization of these metal ions (17,18).
While metal efflux systems have begun to be characterized (16-24), it has been
suggested that in eukaryotes metallothionine (MT), a Cys-rich low-molecular-weight
protein, and glutathione (GSH)-mediated sequestration appears to be the major
mechanism in neutralizing toxic metals (25-29). Ycf1 in S. cerevisiae, a vacuolar
membrane ATP-binding cassette (ABC) transporter, sequesters glutathione-conjugated
Cd (30). Phytochelatin, a GSH polymer synthesized in plants and yeast S. pombe also
detoxifies heavy metals (27). Metal-responsive transcription factor 1 (MTF-1) regulates
basal and metal-inducible expression of MTs and other genes in mammals, fruit fly, and
fish (31-34). In contrast to mammalian genes encoding MT, Cu but not Cd and Zn
induces the Cup1 gene in S. cerevisiae through the ACE1 transcription regulator (35,36).
Consistent to their critical roles in induction of the genes involved in metal detoxification,
deletion of MTF1 in mice and ACE1 in S. cerevisiae, results in enhanced metal sensitivity
(32,35).
In order to gain better insights into the mechanisms of heavy metal metabolism,
we have selected S. cerevisiae cDNAs that suppress Cu sensitivity of the ace1Δ yeast
strain. One of the cDNAs identified encodes the putative P1B-type ATPase, PCA1, which
has been suggested to be involved in Cu and/or Fe homeostasis (37,38). Previously, the
Cd resistance of a mutant yeast strain selected on toxic concentrations of Cd was mapped
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to the PCA1 gene which contained multiple mutations (39). However, the role and
mechanisms of action of PCA1 in metal metabolism have remained elusive. Here we
show that PCA1-mediated Cu resistance is dependent on its Cys-rich amino terminal
domain. The PCA1 allele in all laboratory yeast strains examined carries a missense
mutation in a conserved residue resulting in loss of function. The wild-type PCA1 allele
confers Cd resistance by an efflux mechanism accompanied by a novel mode of metaldependent post-transcriptional regulation.
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2.3.

Experimental Procedures
2.3.1. Yeast Strains, Media, and Phenotypic Tests. Strain BY4741 (MATa

his3∆1 leu2∆0 met15∆0 ura3∆0) and null mutants ace1Δ::KanMX6, pca1Δ::KanMX6
were purchased from Open Biosystems. Strain RM11-1a (40) (MATa leu2∆0 ura3∆0
HO::KanMX6) was kindly provided by Leonid Kruglyak (Fred Hutchison Cancer
Research Center, Seattle, WA). RM11-1a pca1Δ::URA3 and BY4741 ace1Δ::KanMX6
Δpca1:HIS3 were generated by PCR based homologous recombination (41). For
consistency and simultaneous comparisons of Cu and Cd sensitivity, all experiments
unless indicated otherwise were performed using the BY4741 ace1Δ strain. Plasmids
were transformed into yeast using the lithium acetate procedure (42). Yeast cells were
grown on synthetic complete (SC) media (2 % dextrose or galactose, 0.67 % yeast
nitrogen base, and 0.2 % dropout mixture for plasmid selection). For phenotypical
analysis, ~5 μl of yeast cells (OD600 1.0) were spotted on selective media (1.5 % agar)
supplemented with the indicated concentrations of Cd (CdCl2) or Cu (CuCl2) (Sigma) and
incubated at 30 °C for 2 days.
2.3.2. Selection of cDNAs Conferring Cu Resistance. Strain BY4741 ace1Δ
strain was transformed with a yeast cDNA library (43). Transformants (~1x106 colonies)
growing on SC-Ura media were collected by re-suspending in sterilized distilled water,
diluted, and plated on galactose-containing SC-Ura media supplemented with Cu (0.1
mM CuCl2). Plasmids containing cDNA were isolated from yeast colonies growing on
selection media and identified by sequencing. cDNA-dependent Cu resistance was
confirmed by re-transformation of the isolated plasmid into ace1Δ yeast cells.
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2.3.3. Plasmid Construction. The PCA1 ORF (open reading frame) was PCR
amplified from yeast genomic DNA and cloned into BamHI and XhoI restriction sites of a
single-copy yeast expression vector for GPD (p413 GPD) (44) or GAL1 (p413 GAL1)
(45) gene promoter-mediated constitutive expression. The coding sequence of the PCA1
N-terminal domains (aa 1-392 and 1-452) were PCR amplified with a primer set
containing a start codon and artificially generated stop codon, and subcloned into BamHI
and EcoRI sites of p413-GPD. The PCA1 truncation mutant (aa 393-1216) was generated
by PCR amplification of the sequences including start and stop codons, and was
subcloned into p413 GPD at BamHI and XhoI restriction sites. PCA1-GFP and PCA1Flag were constructed by generation of a NotI restriction site after the start codon for
insertion of NotI flanked GFP (green fluorescent protein) without start and stop codons or
two tandem Flag epitopes, respectively. For natural promoter driven expression, the
PCA1 ORF including 810 bp upstream of the start position was cloned into SacI and XhoI
restriction sites of plasmid pRS413 (46). Site-directed mutagenesis was conducted by the
primer overlap extension method (47). All constructs were confirmed by sequencing.
2.3.4. Fluorescence Microscopy. Yeast cells were transformed with PCA1-GFP
or PCA1-WT-GFP expression plasmids and cultured in SC-His media at 30 °C with
agitation until mid-log phase. Metals were added to the culture media for 15 min to 2 hrs
prior to imaging. Cells were collected, washed in phosphate-buffered saline (PBS) and
imaged on a confocal microscope (Olympus FV500).
2.3.5. Metal Measurements. Yeast cells were cultured until mid-log phase and
metal ions were added to the culture media for 6 hours. Cells were collected in 2 mL
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aliquots and washed two times in PBS containing 10 mM EDTA. Cell pellets were
dissolved in 70 % nitric acid at 60 °C for 30 min and diluted to 10 % nitric acid. To
measure Cd excretion, cells were cultured with 5 mM CdCl2 for 30 min, washed two
times in PBS containing 10 mM EDTA, and re-suspended in fresh media prior to sample
collection at the indicated time points. Total cellular metal levels were measured by
inductively coupled plasma mass spectrometry (ICPMS) at the Department of Geological
Sciences, University of Michigan.
2.3.6. Immunoblotting. Total protein extracts were prepared from yeast cells
using glass beads and triton X-100 (1 %) as described previously (48). Protein
concentrations were measured by the BCA method (Pierce) according to the
manufacturer’s specifications. Protein samples were resolved by reducing SDS-PAGE
and transferred to a nitrocellulose membrane. PCA1-GFP was detected by
chemiluminescence using a primary rabbit anti-GFP polyclonal antibody (1:2000) (Santa
Cruz Biotechnology INC.) and secondary goat anti-rabbit HRP-conjugated antibody
(1:5000) (Santa Cruz Biotechnology INC.). PCA1-Flag was probed with primary mouse
anti-Flag M2 monoclonal antibody (1:1000) (Sigma) and secondary sheep anti-mouse
IgG HRP-conjugated antibody (Amersham) (1:5000). Loading control, phosphoglycerate
kinase (PGK), was detected by chemiluminescence using mouse monoclonal anti-PGK
antibodies (1:4,000) (Molecular Probes) and secondary sheep anti-mouse IgG HRPconjugated antibody (1:5,000) (Amersham).
2.3.7. Northern Blotting. Yeast cells were cultured until mid-log phase and
supplemented with either 50 μM CdCl2 or 50 μM CuCl2 for 15 and 60 min. Total RNA
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was extracted from cells and 25 ug was separated on an RNA gel (0.75 % agarose and 2
% formaldehyde) and transferred to a nitrocellulose membrane (Protran). Gene specific
DNA probes labeled with [α-32P]dCTP (Amersham) were generated using the random
primer labeling system (Invitrogen). Hybridization of radio-labeled probes with RNA
transcripts was performed by previously described methods (49). Relative mRNA levels
were detected by autoradiography.
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2.4. Results
2.4.1. The PCA1 N-terminal domain confers Cu resistance in yeast. To
identify new factors involved in heavy metal defense, we carried out a selection of S.
cerevisiae cDNAs that suppress lethality of the ace1Δ yeast strain on toxic Cu media. A
cDNA encoding PCA1, one of two P1B-type ATPases in the S. cerevisiae genome
(37,50), was identified. Yeast GPD gene promoter-driven constitutive expression of
PCA1 confers resistance in the ace1Δ strain to Cu (0.1 mM CuCl2) compared to empty
vector transformed control cells (Fig. 1A). Deletion of PCA1 in the ace1Δ strain resulted
in a slight increase in sensitivity to Cu toxicity (Fig. 2.1A). However, in a wild-type
strain, Cu resistance was not easily discernable upon either over-expression or deletion of
PCA1 (data not shown).
PCA1 contains all of the conserved features of the P1B-type ATPase family which
is specific for heavy metal transport (16-18,51) (Fig. 2.1B). These features include eight
predicted transmembrane domains, where an intramembranous metal-transporting CPx
motif is located in the sixth trans-membrane domain (Fig. 2.1B). The catalytic domains
reside within cytosolic loops which include the nucleotide binding domain (N-domain)
and the phosphorylation domain (P-domain) (Fig. 2.1B). PCA1 contains a single CxxC
heavy metal binding motif located within the N-terminal region. An intriguing feature of
PCA1 compared with other P1B-type ATPases is a Cys-rich N-terminal extension ~550
amino acids before the first trans-membrane domain (Fig. 2.1B). In order to ascertain
whether the observed Cu resistance by PCA1 is dependent on ATPase function, we
carried out site-directed mutagenesis of conserved residues of this family of proteins and
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assayed for Cu sensitivity. However, Cu resistance remained unchanged in all mutants
(Fig. 2.1C), suggesting that Cu resistance is not dependent on metal translocation. Given
that the N-terminus contains several cysteine residues (33 Cys), which could serve as Cu
ligands, we tested whether this domain could independently confer resistance. A peptide
corresponding to amino acid residues 1-452 which includes the CxxC motif (Fig.2.1B)
was expressed in the ace1Δ strain. Expression of this peptide resulted in Cu resistance
above that of full-length PCA1, presumably by chelating Cu ions in a manner analogous
to MT (Fig. 2.1D). Cu resistance is maintained even after mutation of the conserved
CxxC motif (C421A, C423A) (Fig. 2.1D) implying the existence of other Cu
coordination site(s) in addition to this well-characterized metal-binding motif.
2.4.2. Common laboratory yeast strains possess a G970R mutation in PCA1.
S288c is a commonly used S. cerevisiae haploid strain in which its entire genome has
been sequenced (52). Comparisons of the PCA1 sequence of S288c with natural isolates,
RM11-1a

(40)

and

YJM789

(53),

using

BLAST

(NCBI,

http://www.ncbi.nlm.nih.gov/blast/) revealed that the S288c strain carries a single
nucleotide change in the PCA1 gene, which results in a G970R substitution. (Fig. 2.2).
Our sequencing results of PCA1 cloned from the RM11-1a strain as well as an industrial
baker’s yeast strain (Fleischmann’s) confirmed the G970R substitution. In order to
determine if this mutation was unique to the S288c strain, we sequenced the PCA1 ORF
of several laboratory yeast strains, BY4741 (Open Biosystems), DTY1 (54), EG103 (55),
SKY9 (56), and YPH98 (46). All contained the G970R mutation (data not shown), which
suggests a common lineage among theses strains. Furthermore, sequence alignments of
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Figure 2.1. Cu resistance is mediated by the Cys-rich N-terminal domain of
PCA1. A, PCA1 over-expression confers Cu resistance. BY4741 ace1Δ transformed
with empty vector (p413-GPD) or PCA1 expression vector and BY4741 ace1Δ
pca1Δ yeast cells were cultured in SC (SC-His) media and spotted on solid media
supplemented with Cu (CuCl2) at the indicated concentrations. B, Schematic
depiction of PCA1 sequence features. PCA1 contains the signatures of a P1B-type
ATPase, eight predicted transmembrane domains (black boxes), intra-membranous
CPx motif within the sixth transmembrane domain, a CxxC metal binding domain, a
phosphorylation domain (P), and a nucleotide-binding domain (N). The N-terminal
Cys-rich domain is shaded gray. Conserved residues that have been mutated for
characterization are indicated under each domain. C, Cu resistance conferred by
PCA1 is not dependent on metal translocation. BY4741 ace1Δ cells transformed with
empty vector, a PCA1 expression vector or PCA1 with mutations in the CxxC motif
(C421A and C424A), the CPx motif (C859A), or the aspartyl phosphorylation
residue (D903A) were spotted on SC-His media with or without Cu supplementation.
D, Cu resistance is conferred by the PCA1 N-terminus. Cells expressing empty
vector, PCA1, PCA1 residues 1-452, or PCA1 residues 1-452 with site-directed
mutations of the predicted metal-binding cysteines (C421A, C424A) were spotted on
SC-His media with or without Cu supplementation.
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prokaryotic, yeast, plant and human P1B-Type ATPases show that this Gly residue is
invariantly conserved among this family of proteins (Fig. 2.2). Recently, structural
studies of the nucleotide binding domain (N-domain) of two P1B-type ATPases (CopA
and ATP7b) places this Gly residue within an ATP binding pocket (57,58). The
functional importance of this residue is further underscored by an equivalent G1101R
substitution in ATP7b previously reported in patients with Wilson disease (59). Together,
our data along with recent reports strongly support the conclusion that many laboratory S.
cerevisiae strains contain a mutation of a critical residue in PCA1 that may play essential
roles in function, expression, and/or regulation.

Figure 2.2. Yeast laboratory strains contain a G970R mutation in PCA1. A
region of the predicted nucleotide binding domain (N-domain) of PCA1 from strains
S288c, RM11-1a and YJM789 were aligned with the corresponding region of other
P1B-type ATPases, including human Cu-transporting ATP7a and ATP7b, S.
cerevisiae CCC2, A. thaliana HMA4, S. auereous CadA, and A. fulgidus CopA.
Boxes highlight conserved residues. Asterisk marks G970R substitution identified in
the S288c and other laboratory S. cerevisiae strains. Sequences were obtained from
data bases at The National Center for Biotechnological Information (NCBI) and
alignments were performed with ClustalX (1.81).
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2.4.3. PCA1 natural allele confers hyper-resistance to Cd. To characterize the
function of PCA1, we expressed the natural allele (PCA1-WT) and the G970R mutant
allele (PCA1) in a laboratory yeast strain and examined metal tolerance. Indeed,
expression of PCA1-WT allows cells to grow on media containing a Cd concentration
over ten-fold higher compared to vector and PCA1 carrying the G970R mutation.
(Fig.2.3A). However, growth on media supplemented with Cu was indistinguishable,
which is consistent for Cu resistance being dependent on metal binding rather than
ATPase activity (Fig. 2.3A). No growth advantages in cells expressing PCA1-WT were
observed when toxic concentrations of Zn, Mn, Co or Fe were added to growth media
(data not shown), suggesting specificity in metal binding and translocation by PCA1-WT.
Since the RM11-1a strain contains a functional PCA1 allele, it would be predicted
that this strain is more resistant to Cd compared to laboratory strains. Cd sensitivity was
compared between the RM11-1a strain and our BY4741 laboratory strain. Indeed, the
BY4741 strain is much more sensitive to Cd (Fig 2.3B). Deletion of PCA1-WT in the
RM11-1a strain reduces Cd resistance compared to control cells (Fig. 2.3B) underscoring
its significance in Cd defense. Cd tolerance returns to wild-type levels in the RM11-1a
pca1Δ strain transformed with a natural promoter driven PCA1-WT plasmid confirming
that Cd sensitivity was specific for deletion of PCA1-WT (Fig. 2.3B). As expected
deletion of the non-functional PCA1 in the BY4741 strain did not significantly affect Cd
resistance. However, introduction of PCA1-WT under control of its natural promoter
rescued growth on Cd media (Fig. 2.3B). Interestingly, the RM11-1a strain displayed a
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Figure 2.3. PCA1 natural allele (PCA1-WT) plays a critical role in Cd defense. A,
PCA1-WT confers resistance to Cd toxicity. BY4741 ace1Δ cells expressing PCA1 cloned
from a laboratory strain (PCA1) or natural isolate (PCA1-WT) under control of a
constitutive promoter of the GPD gene were spotted on SC-His media supplemented with
CuCl2 or CdCl2 at the indicated concentrations. B, PCA1-WT plays a physiological role in
Cd defense. Cd resistance of laboratory strain BY4741 (BY) was compared to natural
isolate RM11-1a (RM). Wild type BY and RM strains or Δpca1 null mutants were
transformed with empty vector or PCA1-WT under control of its natural promoter. Cells
were spotted on SC-Leu media supplemented with CdCl2 at indicated concentrations. C, Cd
resistance conferred by PCA1-WT is dependent on P1B-type ATPase catalytic activity.
Amino acid substitutions in PCA1-WT were made in the amino terminal CxxC motif
(C421A and C424A), the CPx motif (C859A), or the aspartyl phosphorylation residue
(D903A). Cells expressing PCA1-WT or mutants were spotted on SC-His media
supplemented with indicated concentrations of CdCl2. D, The Cys-rich N-terminus of
PCA1-WT is not essential for Cd resistance. BY4741 ace1Δ cells expressing empty vector,
PCA1-WT, PCA1 ( 1-392) and truncated PCA1-WT (393-1216) were spotted on SC-His
solid media supplemented with the indicated concentrations of CuCl2 or CdCl2.
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Cd growth advantage over the BY4741 strain when PCA1-WT is null-mutated, implying
that there may be other factor(s) contributing to Cd resistance (Fig. 2.3B).
We then asked whether Cd resistance is coupled with active metal transport of a
P1B-type ATPase. Site-directed mutagenesis of conserved amino acids among P1B-type
ATPases, including the CxxC motif (C421, C424), the CPx motif (C859), and the
phosphorylation site (D903), completely abolished Cd resistance (Fig. 2.3C). These
results suggest that Cd resistance is dependent on an active metal transport mechanism.
2.4.4. The Cys-rich N-terminal domain of PCA1 is not essential for Cd
resistance. PCA1 carries a Cys-rich N-terminal domain that does not have significant
sequence homology with any characterized metal-binding protein. We examined the role
of this domain in Cd resistance by expressing the N-terminal 392 amino acid domain and
a truncation PCA1-WT allele lacking this domain. The truncated PCA1-WT allele (aa
393-1216) includes the CxxC motif since it is critical for Cd resistance (Fig. 2.3C). Cells
expressing the N-terminal 392 amino acid peptide are more resistant to both Cd and Cu
compared with empty vector-transformed cells (Fig. 2.3D). Truncation of this N-terminal
domain did not significantly affect Cd resistance as compared to full length PCA1-WT
(Fig. 2.3D). These data suggest that the Cys-rich N-terminal domain itself reduces Cu and
Cd toxicity, but is not critical for Cd transport. In contrast, Cu resistance conferred by
PCA1-WT was abolished in the truncated mutant (Fig. 2.3D), which further supports the
conclusion that Cu resistance conferred by PCA1 is not dependent on ATPase activity but
rather metal sequestration by this domain.
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2.4.5. PCA1-mediated Cd export. We addressed three different possible
mechanisms governing PCA1-WT mediated Cd resistance. First, PCA1-WT could be
involved in Cd sequestration and/or compartmentalization to intracellular organelles. To
test this possibility, total cellular Cd levels were measured by inductively coupled plasma
mass spectrometry (ICPMS) of cells expressing empty vector, PCA1 or PCA1-WT when
cultured in Cd supplemented media. Cells expressing PCA1-WT as compared to empty
vector and PCA1 displayed a marked decrease in total cellular Cd accumulation (Fig.
2.4A). These results indicate that PCA1-WT either reduces Cd uptake or enhances efflux.
Second, to address the possibility that PCA1-WT may indirectly reduce cellular Cd
uptake, yeast cells expressing empty vector or GAL1 promoter-mediated expression of
PCA1-WT were pre-treated with toxic amounts of Cd under glucose repression. Cells
were then washed to remove extracellular Cd and spotted on solid SC media containing
either glucose or galactose. Empty vector-transformed cells and PCA1-WT displayed
similar growth under glucose repression (Fig. 4B). However, cells expressing PCA1-WT
displayed an obvious growth advantage on galactose media in which PCA1-WT is
expressed (Fig. 2.4B). Since PCA1-WT expression was repressed during Cd exposure its
role in Cd defense must occur after Cd has already entered the cell. Third, to conclusively
demonstrate an active efflux role, yeast cells were pre-treated with Cd, washed to remove
extracellular Cd, re-suspended in fresh media, and collected at 30 min intervals to
determine cellular Cd content. Cd levels in cells expressing empty vector remained
relatively constant for 60 min after Cd removal (Fig. 2.4C and inset). In contrast, Cd
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levels rapidly declined in cells expressing PCA1-WT (Fig. 2.4C and inset). All together,
these data strongly support the conclusion that PCA1-WT functions as a Cd efflux pump.
2.4.6. Metal-dependent regulation of PCA1 expression. Since Cd concentration
in the environment likely fluctuates, it is reasonable to predict that Cd regulates PCA1
expression. However, Northern blot analysis did not indicate any induction of the PCA1
gene after the addition of either Cd or Cu to culture media (Fig. 2.5A). Both Cd and Cu
induced GSH1 encoding an enzyme required for GSH synthesis under the same
experimental conditions (Fig. 2.5A). We next examined the possibility of posttranscriptional regulation. Total protein extracts from cells expressing N-terminal Flag
epitope-tagged PCA1-WT were subjected to Western blot analysis. PCA1-WT-Flag and
non-tagged PCA1-WT exhibit indistinguishable Cd resistance indicating that epitope
tagging does not perturb function (data not shown). Although PCA1-WT expression was
mediated by a relatively strong GPD gene promoter, PCA1-WT-Flag was hardly
detectable. However, Cd supplementation to culture media dramatically enhanced PCA1WT-Flag protein levels in a time and dose-dependent manner (Fig. 2.5B). Not only Cd
but also Cu and Ag specifically increased PCA1-WT-Flag protein levels (Fig. 2.5C).
Since the coding sequences of PCA1-WT were inserted into a vector for constitutive
expression by a GPD gene promoter and CYC1 terminator, it is likely that Cd, Cu, and
Ag stabilize PCA1 rather than regulate translation. CCC2, a Cu-transporting P1B-type
ATPase, inserted into the same vector, was not regulated by metal ions supporting the
conclusion that the observed metal regulation of PCA1 is independent of the GPD
promoter and/or CYC1 terminator (data not shown).
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Figure 2.4. PCA1-WT Cd resistance is dependent on an efflux mechanism. A,
Over-expression of PCA1-WT reduces total cellular Cd content. BY4741 ace1Δ cells
transformed with empty vector (p413-GPD) or PCA1 or PCA1-WT expression
vectors were cultured in SC-His media supplemented with Cd (50 μM CdCl2) for six
hours. Cells were collected, washed, and total cellular Cd levels were measured by
ICPMS. Bar graphs represent the average ±S.D. of four independent measurements.
B, BY4741 ace1Δ cells were transformed with an expression plasmid of PCA1-WT
under control of the GAL1 gene promoter or control plasmid. Cells were cultured in
SC-His media supplemented with 1mM CdCl2 for 1 hr under glucose repression,
washed, and spotted on SC-His media containing either glucose (Glu) or galactose
(Gal). C, PCA1-WT enhances Cd efflux. BY4741 ace1Δ cells transformed with
empty vector (closed circles) or a GPD promoter-mediated PCA1-WT expression
vector (open circles). Cells were cultured in SC-His media supplemented with
0.5mM CdCl2 for 30 min, washed and re-suspended in fresh media. Aliquots were
collected at indicated time points and Cd levels were measured. Each data point
represents the average ±S.D. of four independent samples. Inset indicates percent of
initial Cd content.
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Figure 2.5. Metal-dependent regulation of PCA1 expression. A, Cd and Cu do not
induce transcription of PCA1. BY4741 ace1Δ cells were cultured in SC media
supplemented with Cd (50 μM CdCl2) or Cu (50 μM CuCl2) for 15 or 60 min prior to
total RNA extraction. Transcripts of PCA1, GSH1 (a positive control), and ACT1 (a
loading control) were detected by Northern blot analysis using gene-specific 32Plabeled probes. B, Post-transcriptional regulation of PCA1-WT. BY4741 ace1Δ cells
transformed with PCA1-WT-Flag were cultured in SC-His media supplemented with
Cd (1, 10 or 50 μM, CdCl2) for 120 min (left panel) or 50 μM CdCl2 (15, 30 or 120
min) (right panel). PCA1-WT-Flag expression was detected by Western blot analysis.
PGK (phosphoglycerate kinase) was probed as a loading control. C, Metal specific
post-transcriptional regulation of PCA1-WT. BY4741 ace1Δ cells transformed with a
PCA1-WT-Flag expression construct were cultured for 120 min in SC-His media
supplemented with Cd (50 uM CdCl2), Cu (50 uM CuCl2), Ag (25 μM AgNO3), Co
(4 mM CoSO4), Zn (15 mM ZnCl2), Fe (2 mM FeC6H5O7HCl), Mn (15 mM MnCl2),
and Pb (0.2 mM Pb(NO3)2HCl). PCA1-WT-Flag expression was analyzed by
Western blot using anti-Flag antibodies. PGK was probed as a loading control.
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2.4.7. Subcellular localization of PCA1-WT. The function of PCA1-WT as a Cd
efflux pump suggests that it is localized at the plasma membrane. To test this prediction,
both PCA1-WT and PCA1 fused with GFP at the N-terminus were localized by confocal
fluorescence microscopy. The Cd resistance conferred by tagged PCA1-WT-GFP and
untagged PCA1-WT were indistinguishable (data not shown). Under normal conditions
both PCA1 and PCA1-WT display faint fluorescent signals distributed throughout the
cytoplasm (Fig. 2.6A). In accordance with the enhanced protein expression determined
by Western blotting (Fig. 2.5B and 2.5C), the addition of Cd (Fig. 2.6A) as well as Cu
and Ag (data not shown) to culture media dramatically enhanced fluorescent signal in
cells. Furthermore, consistent with a predicted role in Cd efflux, PCA1-WT-GFP is
primarily localized at the plasma membrane in the presence of Cd (Fig. 2.6A) as well as
Cu and Ag (data not shown). Addition of Zn, Fe, Co, Pb, and Mn to the culture media
had no significant effect on fluorescent signals for PCA1-WT-GFP or PCA1-GFP (data
not shown). Expression of the non-functional PCA1-GFP was enhanced by Cd, however
it did not properly localize to the plasma membrane (Fig. 2.6A, 2.6B), suggesting that the
G970R mutation perturbs trafficking. Western blot analysis of PCA1-GFP and PCA1WT-GFP detected a product of the predicted size (Fig. 2.6B), indicating that the GFP
signal reflects full-length PCA1 protein. These data demonstrate that metal ions regulate
PCA1-WT protein levels and stimulate plasma membrane localization.
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Figure 2.6. Metal and functionality-dependent changes in subcellular
distribution of PCA1. A, Subcellular localization of wild-type and nonfunctional
PCA1. BY4741 ace1Δ cells transformed with empty vector, PCA1-WT-GFP or
PCA1-GFP were cultured to mid-log phase with or without Cd (50μM CdCl2)
supplementation for 120 min. Cells were washed and fluorescence was visualized
by confocal microscopy (left panels) and differential interference contrast (right
panels). B, Western analysis of PCA1-GFP fusion proteins. Total protein extracts
were prepared from cells with or without Cd supplementation to the culture media
and PCA1-WT-GFP or PCA1-GFP were detected by Western blot analysis using
anti-GFP antibodies. PGK (phosphoglycerate kinase) was probed as a loading
control.
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2.5. Discussion
The P-type ATPase family of integral membrane proteins translocates various
ions and phospholipids across membranes using the chemical energy of ATP hydrolysis
(15-18,51,60-62). Virtually all organisms rely on these transporters for maintaining a
transmembrane gradient of various ions, which are vital for nutrient uptake,
neurotransmission, signaling, and excretion of toxic metals (15-18,51,60-62). The P1Btype ATPase specifically transports soft metals, such as Cu, Cd, Zn and Pb (13-18). Our
data presented herein support the conclusion that PCA1, one of the two P1B-type
ATPases in the S. cerevisiae genome, is a Cd efflux pump which is non-functional in all
five laboratory yeast strains that we have examined. Metal-induced stabilization and
distribution of PCA1 at the plasma membrane is likely an important mechanism of rapid
response to excess Cd. This is a novel mode of regulation identified in this family of
proteins. Function, structural features and metal-dependent regulation patterns of PCA1
revealed important new insights into the classification, substrate specificities,
mechanisms of action, and regulation of P1B-type ATPases. Moreover, this study also
uncovered that S. cerevisiae laboratory strains that have been used widely as an
outstanding model system in biomedical sciences does not mirror, at least in cellular Cd
defense, the strains living in natural habitats.
PCA1 has been proposed and classified as a Cu-transporting P1B-type
ATPase (37). However our data does not support a Cu-transporting function. Instead the
Cys-rich N-terminal domain appears to be the contributing factor involved in Cu
resistance. The abundant Cys residues may serve as ligands for Cu binding. Expression of
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this domain itself confers Cu tolerance in yeast, which supports the hypothesis that these
abundant Cys residues participate in metal coordination. However, detoxification of Cugenerated reactive oxygen species (4) by this domain can not be excluded as superoxide
dismutase activity has been reported for the similar Cys-rich MT (63). It is interesting to
note that AtHMA2 and AtHMA4, two P1B-type ATPases of A. thaliana, possess a
similar Cys/His-rich domain at the C-terminus (19,21,22). However, these domains do
not show significant sequence identity with each other or with any other known metalbinding proteins. It appears that this region is not essential for AtHMA2/4 function
(64,65). Consistently, truncation of the Cys-rich N-terminal domain, excluding the CxxC
motif, does not alter PCA1-WT mediated Cd resistance. This region may play regulatory
roles through interaction with metals and/or with other proteins. Several Ca++transporting P-type ATPases were shown to carry autoinhibitory domains (51,60).
Binding of regulators and phosphorylation of C-teminal residues of H+-transporting
ATPases in plants has also been reported (51,61,66). We are currently testing the
regulatory roles of the Cys-rich N-terminal domain of PCA1.
A conserved signature of P1B-type ATPase family is the one to six CxxC motifs
located within the N-terminal region (67). For instance, human ATP7a and ATP7b
contain six such motifs. The two Cys residues bind a single Cu (Cu+) ion in a linear
bicoordinate manner (68). While Cu binding to these motifs is firmly established by
several methods, their roles in the function and regulation of ATP7a and ATP7b remain
unclear. These motifs have been suggested to influence Cu translocation and/or
subcellular trafficking of ATP7a and ATP7b (67). Site-directed mutagenesis of the CxxC
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motif in PCA1 showed that the two Cys residues are necessary for Cd resistance, which
suggests Cd binding to this domain is critical for PCA1 function. Cd coordination
unlikely occurs through two Cys residues but rather with multiple ligands. Future metal
binding studies and structural characterization of the Cys-rich domain would reveal how
PCA1 coordinates Cd or other metal ions. Distinct structural features for metal
coordination of this domain may explain substrate specificity of P1B-type ATPases.
Given that the cytosolic Cu carrier, Atox1, directly interacts with the metal binding
domain of ATP7a and ATP7b, PCA1 may acquire Cd from a carrier molecule. Since Cd
binds thiol groups (25-29), glutathione and/or other cytosolic Cd carriers may specifically
interact with the PCA1 metal binding domain to transfer Cd. For instance, YCF1, a
vacuolar ABC transporter utilizes bis(glutathionato)Cd as its substrate (30).
P1B-type ATPases are categorized into several subfamilies depending on
substrates and structural features (69), although the molecular determinant(s) for the
substrate specificities is not known. Given that PCA1 deletion or over-expression
specifically alters cellular accumulation and resistance of Cd, PCA1 appears to be the
first Cd-specific P1B-type ATPase. It is possible that PCA1 may efflux other heavy metal
ions but since they do not enhance protein expression, substrate specificity can not be
deciphered by metal resistance. We have addressed this issue by the generation of a
functional PCA1 mutant which is constitutively expressed even in the absence of Cd (D.
Adle and J. Lee, unpublished data). Additionally, in vitro biochemical ATPase assays
would further define PCA1 substrate specificity.
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Sequence analysis of the PCA1 ORF of two independent natural strains, and an
industrial strain clearly identified a G970R mutation to exist in all examined laboratory
strains. Although a few other polymorphisms exist, all carried the G970R substitution. It
is likely that the ancestral S. cerevisiae laboratory strain carrying the original G970R
mutation was propagated to several research laboratories across the world. Interestingly,
a PCA1 allele containing several (27 amino acid) missense mutations was identified in a
yeast strain that was selected on media containing lethal concentrations of Cd (39).
Among these mutations, an R970G mutation was implicated in Cd resistance conferred
by the mutant PCA1 (39). Thus, it appears that in this report a non-functional PCA1
mutant was reverted to the functional allele under Cd stress. The non-functional PCA1
allele, at least partially, explains Cd sensitivity of a laboratory strain (BY4741) compared
with a natural isolate (RM11-1a). The RM11-1a strain was still hyper-resistant compared
to BY4741 even when PCA1 was deleted in these strains, implicating the existence of
other contributing factors involved in Cd defense. Elucidation of the underlying reason of
Cd hyper-resistance in the RM11-1a strain would lead to a better understanding of
mechanisms involved in Cd detoxification.
Regulation of subcellular distribution and transcription of P1B-type ATPases
have been previously reported, suggesting the significance of active regulation of this
family of transporters. ATP7a and ATP7b localize to the ER-golgi membrane where they
transport Cu across the membrane for incorporation into proteins in the secretory
pathway (7,16,50,67). Excess cellular accumulation of Cu induces trafficking of ATP7a
to the plasma membrane and ATP7b to cytoplasmic vesicles (67). In addition to post-
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translational regulation, several examples of metal-dependent transcriptional regulation
of genes encoding P1B-type ATPases have been reported in plant, yeast, and bacteria
(19,21,70-73). PCA1 mRNA levels are not regulated by Cd or Cu. However, Cd
dramatically regulates PCA1 protein levels and promotes localization to the plasma
membrane, which is a unique mode of regulation for this family of transporters.
Interestingly, Cu and Ag also regulate PCA1 protein expression, although PCA1 does not
transport these metals. Since the N-terminus of PCA1 possesses a Cys-rich region which
likely binds Cu, it is plausible that metal binding to this domain controls turnover of
PCA1.
Given that the Gly970 residue in PCA1 is conserved among this family of
proteins and has been positioned in an ATP binding pocket of two independent structures
of P1B-type ATPases (58,74), it is likely that this residue is involved in ATP binding.
Interestingly, the G970R mutant exhibits a distinct localization pattern compared with
that of PCA1-WT. An equivalent mutation identified in ATP7b of Wilson disease
patients might also lead to defects in subcellular distribution. A specific conformation
resulting from ATP binding and metal translocation may determine proper trafficking of
PCA1. This may occur through PCA1 conformation-dependent attraction of secretory
and/or endocytosis machinery. We are currently exploring these possibilities.
Cd is one of the most toxic environmental pollutants. It is removed slowly from
the body, which may be due to high affinity binding to cellular ligands, such as thiol
groups in proteins, glutathione, methallothionein, and cysteine. Cd transporters in
hepatocytes and renal epithelial cells, such as ATP-binding cassette, multi-drug resistance
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protein, GSH-Cd complex transporter, have been proposed to efflux GSH or Cysconjugated Cd (23,24). However, no report has identified other P1B-type ATPases in the
human genome in addition to ATP7a and ATP7b. Further characterization of Cd efflux
systems in higher eukaryotes would advance our ability to combat Cd-related disorders
and develop methods for remediation of toxic heavy metals.

69
2.6. Literature Cited
1. Nelson, N. (1999) EMBO J. 18, 4361-4371
2. Pena, M. M., Lee, J., and Thiele, D. J. (1999) J. Nutr. 129, 1251-1260
3. Hentze, M. W., Muckenthaler, M. U., and Andrews, N. C. (2004) Cell 117, 285-297
4. Halliwell, B., and Gutteridge, J.M. (1990) Methods Enzymol. 186, 1-85
5. Vallee, B.L., and Ulmer, D.D. (1972) Annu. Rev. Biochem. 41, 91-128
6. Bush, A.I. (2000) Curr. Opin. Chem. Biol. 4, 184-191
7. Tao, T.Y., and Gitlin, J.D. (2003) Hepatology 37, 1241-1247
8. Ercal, N., Gurer-Orhan, H., and Aykin-Burns, N. (2001) Curr. Top. Med. Chem. 1,
529-539
9. Henson, M.C., and Chedrese, P.J. (2004) Exp. Biol. Med (Maywood). 229, 383-392
10. McMurray, C.T., and Tainer, J.A. (2003) Nat. Genet. 34, 239-241
11. Darbre, P.D. (2006) J. Appl. Toxicol. 26, 191-197
12. Stoica, A., Katzenellenbogen, B.S., and Martin, M.B. (2000) Mol. Endocrinol. 14,
545-553
13. Silver, S., and Phung, L.T. (1996) Annu. Rev. Microbiol. 50, 753-789
14. Nies, D.H. (1999) Appl. Microbiol. Biotechnol. 51, 730-750
15. Gatti, D., Mitra, B., and Rosen, B.P. (2000) J. Biol. Chem. 275, 34009-34012
16. Solioz, M., and Vulpe, C. (1996) Trends Biochem. Sci. 21, 237-241
17. Axelsen, K.B., and Palmgren, M.G. (2001) Plant. Physiol. 126, 696-706
18. Williams, L.E., and Mills, R.F. (2005) Trends Plant. Sci. 10, 491-502
19. Papoyan, A., and Kochian, L.V. (2004) Plant Physiol.136, 3814-3823

70
20. Hussain, D., Haydon, M.J., Wang, Y., Wong, E., Sherson, S.M., Young, J.,
Camakaris, J., Harper, J.F., and Cobbett, C.S. (2004) Plant Cell 16, 1327-1339
21. Eren, E., and Argüello, J.M. (2004) Plant Physiol. 136, 3712-3723
22. Verret, F., Gravot, A., Auroy, P., Leonhardt, N., David, P., Nussaume, L., Vavasseur,
A., and Richaud, P. (2004) FEBS Lett. 576, 306-312
23. Ballatori, N. (2002) Environ. Health Perspect. 110 (Suppl 5), 689-694
24. Zalups, R.K., and Ahmad, S. (2003) Toxicol. Appl. Pharmacol.186, 163-188
25. Hamer, D.H. (1986) Annu. Rev. Biochem. 55, 913-951
26. Klaassen, C.D., Liu, J., and Choudhuri, S. (1999) Annu. Rev. Pharmacol. Toxicol. 39,
267-294
27. Cobbett, C., and Goldsbrough, P. (2002) Annu. Rev. Plant. Biol. 53, 159-182
28. Singhal, R.K., Anderson, M.E., and Meister, A. (1987) FASEB J. 1, 220-223
29. Wimmer, U., Wang, Y., Georgiev, O., and Schaffner, W. (2005) Nucleic Acids Res.
33, 5715-5727
30. Li, Z.S., Lu, Y.P., Zhen, R.G., Szczypka, M., Thiele, D.J., and Rea, P.A. (1997) Proc.
Natl. Acad. Sci. U. S. A. 94, 42-47
31. Lichtlen, P., and Schaffner, W. (2001) Bioessays 23, 1010-1017
32. Wang, Y., Wimmer, U., Lichtlen, P., Inderbitzin, D., Stieger, B., Meier, P.J.,
Hunziker, L., Stallmach, T., Forrer, R., Rulicke, T., Georgiev, O., and Schaffner, W.
(2004) FASEB J. 18, 1071-1079
33. Heuchel, R., Radtke, F., Georgiev, O., Stark, G., Aguet, M., and Schaffner, W. (1994)
EMBO J. 13, 2870-2875

71
34. Palmiter, R.D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1219-1223
35. Thiele, D.J. (1988) Mol. Cell. Biol. 8, 2745-2752
36. Zhou, P., and Thiele, D.J. (1993) Biofactors 4, 105-115
37. Rad, M.R., Kirchrath, L., and Hollenberg, C. P. (1994) Yeast 9, 1217-1225
38. De Freitas, J.M., Kim, J.H., Poynton, H., Su, T., Wintz, H., Fox, T., Holman, P.,
Loguinov, A., Keles, S., van der Laan, M., and Vulpe, C. (2004) J. Biol. Chem. 279,
4450-4458
39. Shiraishi, E., Inouhe, M., Joho, M., and Tohoyama H. (2000) Curr. Genet. 37, 79-86
40. Brem, R.B., Yvert, R., Clinton, R., and Kruglyak, L. (2002) Science 296, 752-755
41. Longtine, M. S, McKenzie, Mckenzie III, A., Demarini D. J., Shah N. G., Wach A.,
Brachat, A., Phillippsen, P., and Pringle, J. R., (1998) Yeast 14, 953-961
42. Geitz, D. R., Schiestl, R.H., Willems, A. R., and Woods R. A. (1995) Yeast 11, 355360
43. Liu, H., Krizek, J., and Bretscher, A. (1992) Genetics 132, 665-73
44. Mumberg, D., Müller R., and Funk, M. (1995) Gene 156, 119-122
45. Johnston, M., and Davis, R.W. (1984) Mol. Cell. Biol. 4, 1440-1448
46. Sikorski, R.S., and Hieter, P. (1989) Genetics 122, 19-27
47. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., and Pease, L.R. (1989) Gene
(Amst.) 77, 51-59
48. Pena, M.M., Puig, S., and Thiele, D.J. (2000) J. Biol. Chem. 275, 33244-33251
49. Lee, J., Petris, M.J., and Thiele, D.J. (2002) J. Biol. Chem. 277, 40253-40259

72
50. Yuan, D.S., Stearman, R., Dancis, A., Dunn, T., Beeler, T., and Klausner, R.D.
(1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2632-2636
51. Kuhlbrandt, W. (2004) Nat. Rev. Mol. Cell. Biol. 5, 282-295
52. Goffeau, A., Barrell, B.G., Bussey, H., Davis, R. W., Dujon, B., Feldmann, H.,
Galibert, F., Hoheisel, J. D., Jacq, C., Johnson, M., et al. (1996) Science 274, 563-567
53. Tawfik, O.W., Papasian, C.J., Dixon, A.Y., and Potter, L.M. (1989) J. Clin.
Microbiol. 27, 1689-1691
54. Rymond, B.C., Zitomer, R.S., Schumperli D., and Rosenberg M. (1983) Gene 25,
249-262.
55. Gralla, E.B., and Valentine, J.S. (1991) J. Bacteriol. 173, 5918-5920
56. Knight, S.A., Labbé, S., Kwon, L.F., Kosman, D.J., and Thiele, D.J. (1996) Genes
Dev. 10, 1917-1929
57. Sazinsky, M.H., Mandal, A.K., Argüello, J.M., and Rosenwieg, A.C. (2006) J.
Biochem. 281, 11161-11166
58. Dmitriev, O., Tsivkovskii, R., Abildgaard, F., Morgan, C.T., Markley, J.L., and
Lutsenko S. (2006) Proc. Nat. Acad Sci. U. S. A. 103, 5302-5307
59. Thomas, G.R., Forbes, J.R., Roberts, E.A., Walshe, J.M., and Cox, D.W (1995) Nat.
Genet. 9, 210-217
60. Toyoshima, C., and Inesi, G. (2004) Annu. Rev. Biochem. 73, 269-292
61. Palmgren, M.G. (2001) Annu. Rev. Plant. Physiol. Plant. Mol. Biol. 52, 817-845
62. Kaplan, J.H. (2002) Annu. Rev. Biochem. 71, 511-535

73
63. Tamai, K.T., Gralla, E.B., Ellerby, L.M., Valentine, J.S., and Thiele, D.J. (1993)
Proc. Natl. Acad. Sci. U. S. A. 90, 8013-8017
64. Mills, R.F., Francini, A., Ferreira da Rocha, P.S., Baccarini, P.J., Aylett M, Krijger,
G.C., and Williams, L.E. (2005) FEBS Lett. 579, 783-791
65. Eren, E., Kennedy, D.C., Maroney, M.J., and Argüello, J.M. (2006) J. Biol. Chem. In
press
66. Portillo, F. (2000) Biochim. Biophys. Acta. 1469, 31-42
67. Lutsenko, S., and Petris, M.J. (2003) J. Membr. Biol. 191, 1-12
68. Gitschier, J., Moffat, B., Reilly, D., Wood, W.I., and Fairbrother, W.J. (1998) Nat.
Struct. Biol. 5, 47-54
69. Argüello, J.M. (2003) J. Membr. Biol. 195, 93-108
70. Mills, R.F., Krijger, G.C., Baccarini, P.J., Hall, J.L., and Williams, LE. (2003) Plant
J. 35, 164-176
71. Wunderli-Ye, H., and Solioz, M. (1999) Adv. Exp. Med. Biol. 448, 255-264
72. Rensing, C., Fan, B., Sharma, R., Mitra, B., and Rosen, B.P. (2000) Proc. Natl. Acad.
Sci. U. S. A. 97, 652-656
73. Andres-Colas, N., Sancenon, V., Rodriguez-Navarro, S., Mayo, S., Thiele, D.J.,
Ecker, J.R., Puig, S., and Penarrubia, L. (2006) Plant J. 45, 225-236.
74. Sazinsky, M.H., Mandal, A.K., Argüello, J.M., and Rosenzweig, A.C. (2006) J. Biol.
Chem. 281, 11161-11166

74

Chapter 3

Expressional Control of a Cadmium-Transporting P1B-Type
ATPase by a Metal Sensing Degradation Signal
Note: The results described in this chapter have been published
The authors and title of the paper are:
David J. Adle and Jaekwon Lee (2008) Expressional Control of a Cadmium-Transporting
P1B-Type Atpase by a Metal Sensing Degradation Signal. J. Biol. Chem. 283, 3146031468
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3.1. Abstract
Cadmium is a highly toxic environmental contaminant implicated in various
diseases. Our previous data demonstrated that Pca1, a P1B-type ATPase, plays a critical
role in cadmium resistance in yeast S. cerevisiae by extruding intracellular cadmium.
This illustrates the first cadmium-specific efflux pump in eukaryotes. In response to
cadmium, yeast cells rapidly enhance expression of Pca1 by a post-transcriptional
mechanism. To gain mechanistic insights into the cadmium-dependent control of Pca1
expression, we have characterized the pathway for Pca1 turnover and the mechanism of
cadmium sensing that leads to up-regulation of Pca1. Pca1 is a short-lived protein (t1/2<5
min) and is subject to ubiquitination when cells are growing in media lacking cadmium.
Distinct from many plasma membrane transporters targeted to the vacuole for
degradation via endocytosis, cells defective in this pathway did not stabilize Pca1.
Rather, Pca1 turnover was dependent on the proteasome. These data suggest that, in the
absence of cadmium, Pca1 is targeted for degradation before reaching the plasma
membrane. Mapping of the N-terminus of Pca1 identified a metal-responding degradation
signal encompassing amino acids 250 to 350. Fusion of this domain to a stable protein
demonstrated that it functions autonomously in a metal-responsive manner. Cadmium
sensing by cysteine residues within this domain circumvents ubiquitination and
degradation of Pca1. These data reveal a new mechanism for substrate-mediated control
of P1B-type ATPase expression. Cells have likely evolved this mode of regulation for a
rapid and specific cellular response to cadmium.
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3.2. Introduction
While several heavy metals are essential micronutrients, many of them are toxic
environmental contaminants with no physiological role. Genetic disorders in metal
metabolism (e.g., hemochromatosis and Wilson disease) in which excess iron and copper
are accumulated in the liver, respectively (1-3), provide striking evidence for the toxicity
of nutritional metal ions. Cadmium is a highly toxic environmental contaminant linked to
a series of diseases in humans and animals, including renal disease, cancer, reproductive
defects, and endocrine disruption (4-5). Human exposure to cadmium through diet,
smoking, pollution, and occupation is widespread (4,5). Cadmium released into the
environment enters the food chain through its accumulation in plants, fish, shellfish, and
other animals (4-7). Cadmium concentrations in plants usually range from 0.5 to 5 μM
(6); however, in some plants, it can reach more than 100 μM (8). High levels of cadmium
can be accumulated in soil due to pollution, abandoned mines, or geological features. The
content of cadmium and acidity of soils determine cadmium levels in grains and
vegetables produced from the land (4,7,8).
Cadmium has a high affinity for sulfhydryl (–SH) groups in proteins and
glutathione, a major cellular reducing buffer, which results in inactivation of proteins and
cellular oxidative stress (4,9,10). A recent report showed that cadmium markedly
increases mutation rates by specifically inhibiting the DNA mismatch repair system (11).
Cadmium exposure during pregnancy is associated with low birth weight and increased
incidence of spontaneous abortion (4,7,11-14). Cadmium affects steroid synthesis
pathways and secretion of progesterone, a hormone that plays critical roles in maintaining
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pregnancy (12). Cadmium induces uterine hyperplasia, mammary gland development,
and early onset of puberty in rat models (13,14). These estrogenic effects lead to
infertility and cancer (14). Moreover, cadmium could exhibit synergistic estrogenic
effects with other xenoestrogens, such as phytoestrogens in soybeans and vegetables (14).
Organisms have evolved systems for excretion and detoxification of nonphysiological metals and homeostatic acquisition of nutritional yet toxic metals. Metal
transporters, cytosolic delivery molecules, and chelators have been identified in many
organisms ranging from bacteria to humans (1,3,26-28). Given that cadmium is not a
nutritional metal ion, organisms do not actively acquire cadmium. Rather, cadmium
enters the body through non-specific mechanisms and/or transporters involved in the
acquisition of essential metal ions. DMT1 (DCT1, Nramp2) iron transporter, zinc
transporters, and calcium channels are all involved in cadmium absorption (15-19).
Metallothionein (MT), a cysteine-rich low molecular weight metal-chelating peptide, and
glutathione (GSH), a cysteine-containing tripeptide, sequester metal ions. In eukaryotes,
this is considered the major mechanism for neutralizing toxic metals, including cadmium
(20-23). Ace1 is a transcription factor inducing expression of copper defense genes in S.
cerevisiae, including CUP1 and CRS5 encoding metal chelators, and SOD1 encoding a
superoxide dismutase (24). Ycf1, a vacuolar membrane ATP-binding cassette (ABC)
transporter, sequesters glutathione-conjugated cadmium and other metals into the vacuole
(25). Thus, Δace1 and Δycf1 strains are sensitive to copper and cadmium, respectively.
Phytochelatin, a GSH polymer synthesized in plants and fission yeast, also chelates heavy
metals (21). Several heavy metal efflux pumps, including P1B-type ATPases, ABC
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transporters, and cation diffusion facilitators play roles for extruding toxic heavy metals
(3,26-28). These metal-transporters play vital roles for uptake, compartmentalization, and
extrusion of nutritional and non-physiological heavy metals. In bacterial cells, P1B-type
ATPases are vital for extrusion of metals, including cadmium, copper, and lead (26, 27).
However, the cadmium efflux systems in eukaryotes remain uncharacterized.
Consistent to the fact that cellular defense systems respond to metal levels,
several modes of regulation control expression, subcellular localization, and activities of
P1B-type ATPases. Transcriptional control appears to be a major regulatory mechanism in
bacteria and plants (26-28). In mammals copper controls subcellular trafficking of
copper-transporting P1B-type ATPases. In a low copper medium, ATP7a and ATP7b are
localized in the trans-Golgi network where they transport copper for its incorporation
into secretory proteins (3,29). When copper levels are elevated, ATP7a is mobilized to
the plasma membrane in a reversible manner (3,29). The biological significance of this
molecular event is that ATP7a participates in copper uptake at the intestine and protects
cells from copper toxicity. Excess copper mobilizes ATP7b from the trans-Golgi network
to cytoplasmic vesicle-like compartments in the liver (3,29), which appears to be an
important mechanism for excretion of excess copper into bile to maintain systemic
copper homeostasis.
In a previous study, we demonstrated that Pca1, a predicted P1B-type metaltransporting ATPase, is critical for cadmium defense in yeast S. cerevisiae (30). Pca1 is
rapidly up-regulated in response to cadmium without any change in its transcript levels
(30), which suggests a new mode of substrate-mediated regulation for this family of

79
proteins. To elucidate the mechanisms underlying the expressional control of Pca1 in
response to cadmium, we have characterized the pathways for turnover of Pca1 and
identified a metal-sensing cis-acting element that controls turnover of Pca1. Our data
demonstrate that a degradation signal within the cysteine-rich N-terminus rapidly targets
Pca1 for ubiquitination and degradation by the proteasome. This occurs before Pca1
reaches the plasma membrane where it extrudes cadmium. However, direct cadmium
sensing by the degradation signal prevents turnover, which leads to enhanced expression
of Pca1. Cells have likely evolved this mode of regulation for a rapid and specific
response against cadmium. Together, we have identified a new metal binding domain and
revealed a unique mode of regulation for a P1B-type ATPase by its own substrate.
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3.3. Experimental Procedures
3.3.1. Yeast Strains, Media, and Growth Conditions. A BY4741 haploid S.
cerevisiae strain (MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0) and null mutants, including
ace1::KanMX6, ycf1:: KanMX6, pep4:: KanMX6, vps4::KanMX6 and pdr5:: KanMX6
strains, were purchased from OpenBiosystems. Gene deletion in each strain was
confirmed by PCR using gene specific primer sets. We received end4-1 (31), npi1 (32),
and pre1-1pre2-1 (33) strains from Drs. Caroline Philpott, (National Institute of Health),
Bruno André, (Universite Libré de Bruxelles), and Dieter Wolf (Universität Stuttgart),
respectively. Yeast cells were cultured with synthetic complete (SC) media (2% dextrose,
0.2% amino acid mixture, and 0.67% yeast nitrogen base) lacking specific amino acids
for plasmid selection. If no temperature is specified, cells were cultured at 30 oC. For
phenotypical analysis on solid media (1.5% agar), 5 μl of yeast cells (OD600 1.0) were
spotted on selective media supplemented with the indicated concentrations of cadmium
(CdCl2) or copper (CuCl2) and incubated at 30 °C for 2 days before photography.
Cycloheximide chases were performed by the addition of 100 ug/mL cycloheximide to
logarithmically growing cultures prior to collection into equal volumes of ice-cold kill
buffer (phosphate buffered saline (PBS) containing 15 mM NaN3) at the indicated time
points. For proteasome inhibition, a Δpdr5 strain that blocks proteasome inhibitor efflux
(34), was cultured 5 hrs in the presence of 40 µM MG132 (Calbiochem) in 0.1% dimethyl
sulfoxide (Sigma).
3.3.2. Plasmid Construction and Manipulation. If no expression vector is
specified, single copy yeast vectors (p416-GPD) (35) were used for glyceradehyde-3-
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phosphate dehydrogenase (GPD) gene promoter-driven constitutive expression of Pca1,
N-terminal truncated Pca1, CaCRP, Pca1-CaCRP fusion, N-terminal 250-350 peptide,
Fet3 iron oxidase, CL1 degradation signal peptide, and Gap1 general amino acid
permease. For the green fluorescent protein (GFP) or hemagglutinin (HA) epitope fusion,
NotI flanked GFP or three tandem HA epitopes were inserted into the NotI site which was
artificially generated after ATG translation start codon by PCR. Expression plasmids of
CL1 artificial degradation signal fused with GFP were constructed as described (36,45).
Site-directed mutagenesis was conducted by the primer overlap extension method (37).
We sequenced all constructs to confirm correct sequence and in frame fusion. Common
molecular biology techniques, including plasmid amplification using Escherichia coli,
and purification, followed previously established methods (38). Plasmid transformation
into yeast was performed using the lithium acetate method (39).
3.3.3. Fluorescence Microscopy. Yeast cells were cultured in SC selective media
at 30 °C with agitation until mid-log phase. When indicated, metals (CdCl2 or CuCl2)
were added to the culture media prior to imaging. Cells were collected, re-suspended in
PBS and imaged on a confocal microscope (Olympus FV500) as described (30).
3.3.4. Immunoblotting. Total protein extracts were prepared by breaking cells
with glass beads in PBS containing protease inhibitor cocktail (Complete Mini) (Roche)
and 1% triton X-100. Protein concentrations were measured using the BCA kit (Pierce)
according to the manufacturer’s specifications. Lysates were denatured in SDS sample
buffer containing dithiothreitol (DTT) (25 mM) for 15 min at 37 °C and resolved by
SDS-PAGE and transferred to a nitrocellulose membrane. GFP fusion proteins were
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detected by rabbit anti-GFP polyclonal antibodies (Santa Cruz Biotechnology INC) and
secondary goat anti-rabbit IgG antibodies conjugated to horseradish peroxidase (HRP)
(Santa Cruz Biotechnology INC). HA-tagged proteins were probed with rabbit anti-HA
polyclonal antibodies (Rockland) and secondary goat anti-rabbit IgG antibodies
conjugated to HRP (Santa Cruz Biotechnology INC). Loading control, 3phosphoglycerate kinase (PGK), was detected with mouse monoclonal anti-PGK
antibodies (Molecular Probes) and secondary sheep anti-mouse IgG antibodies
conjugated to HRP (Amersham). Signals were captured on film (Midwest Scientific) by
chemiluminescence (SuperSignal West Pico) (Pierce).
3.3.5. Detection of Ubiquitination. Cells were broken by glass beads in PBS
containing protease inhibitors (Complete Mini) (Roche), 5 mM N-ethylmaleimide, 1 mM
phenyl-methylsulfonyl fluoride, and 1% Triton X100. HA-tagged proteins were
immunoprecipitated with an HA-Tag IP/Co-IP kit (Pierce) according to manufacturer
specifications. Proteins were eluted by incubation of immobilized anti-HA agarose beads
in 2XSDS sample buffer at 37 °C for 15 min and reduced in the presence of 0.1 M DTT
for an additional 15 min at 37 °C. Ubiquitin-conjugated proteins were detected by
immunoblotting using mouse monoclonal antibodies against ubiquitin (Covance).
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3.4. Results
3.4.1. Cadmium Rapidly Induces Pca1 Expression by Increasing Stability. A
unique feature of Pca1 is a cytosolic cysteine-rich N-terminal extension of nearly 400
residues (Fig. 3.1A). To investigate the mechanism underlying the post-transcriptional
regulation and role of the N-terminal extension in turnover of Pca1, we have constructed
expression plasmids of full length Pca1 and Pca1 with truncation of the first 392 amino
acids. A GFP or triple HA epitope was fused at the N-terminus. All Pca1 constructs were
functional in conferring cadmium resistance (Fig. 3.1B). Western blot analysis of Pca1
showed that Pca1 is a short-lived protein (t1/2 < 5min) (Fig. 3.1C). However, upregulation of Pca1 is clearly visible 5 min after addition of cadmium to culture media
(Fig. 3.1D), indicating a rapid cellular response to cadmium. Pca1 tagged with the GFP or
c-myc epitope at the N or C-terminus, respectively, also showed similar regulation by
cadmium (data not shown), suggesting that cadmium’s effect on Pca1 expression is
independent of epitope or its location. This expression control by cadmium can be
explained by enhanced translation or stability of Pca1 protein. To decipher these two
possibilities, Pca1 turnover rate was examined by cycloheximide chases in the absence or
presence of cadmium in culture media. Indeed, stability of Pca1 is dramatically increased
in the presence of cadmium (Fig. 3.1E). These data suggest that the induction of Pca1
occurs through cadmium’s ability to prevent the rapid turnover of Pca1.
3.4.2. Pca1 Is Not Stabilized in a Strain Defective in Endocytosis. In yeast,
several plasma membrane proteins are internalized into endocytic vesicles that enter the
early
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Figure 3.1. Cadmium rapidly enhances Pca1 expression by increasing stability. A,
Schematic depiction of the Pca1 P1B-type ATPase. Gray and black rectangles represent
the N-terminal cysteine-rich cytosolic domain encompassing the first 392 amino acids
and eight predicted transmembrane domains, respectively. B, Cadmium resistance in
cells expressing Pca1 alleles. Pca1, N-terminal GFP-fused Pca1 (GFP-Pca1), three
tandem HA epitope-tagged Pca1 (HA-Pca1), and Pca1 deleted of the N-terminal
cysteine-rich domain (Pca1Δ392) with or without N-terminal GFP fusion were
expressed in a BY4741 yeast strain in which endogenous Pca1 is non-functional (30).
Cells (5 μl, OD600 1.0) were spotted on SC solid media containing the indicated
concentration of CdCl2, and then cell growth was assessed after two days. C, D, and E,
HA-Pca1 expression was detected by Western blotting using anti-HA antibodies. The
same blot was probed for PGK to determine equal loading. C, Cycloheximide chase of
yeast cells expressing HA-Pca1. Exponentially growing cells were co-cultured with
cycloheximide (100 µg/mL) and then collected at the indicated time points for Western
blot analysis. D, Rapid up-regulation of Pca1 in response to cadmium. Cadmium (50
μM CdCl2) was added to exponentially growing yeast cultures, and then cells were
collected into ice-cold kill buffer (15 mM NaN3 PBS) at the indicated time points. E,
Cadmium-induced stabilization of Pca1 determined by cycloheximide chase. Yeast
cells pre-cultured for 15 min without (NT) or with cadmium (20 μM CdCl2) were
collected at the indicated time points. Cycloheximide (100 µg/mL) was added to the
culture media after collection of time zero. Total protein extracts were subject to
Western blot analysis.
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endosome where they can be recycled back to the surface or are delivered to the vacuole
for degradation (40,41). We considered that Pca1 might be transiently localized at the
cell surface before being rapidly internalized and degraded. In this pattern of trafficking,
cadmium sensing would shift the distribution of Pca1 to the cell surface for cadmium
efflux. If the internalization step were to be blocked then Pca1 would be expected to
accumulate at the plasma membrane in the absence of cadmium. To test this possibility,
we investigated the subcellular localization of Pca1 fused with GFP (Fig. 3.1B) in a strain
harboring a temperature-sensitive allele of END4. This strain exhibits conditional defects
in both fluid phase and receptor-mediated endocytosis at the restrictive temperature (31).
Confocal microscopy revealed that GFP-Pca1 expressed in the end4-1 mutant at the
restrictive temperature did not accumulate at the plasma membrane (data not shown) and
remained unstable as demonstrated by cycloheximide chase (Fig. 3.2A). The defect in
endocytosis was confirmed by inhibition of internalization of the membrane impermeable
dye, Lucifer Yellow CH (31) in the end4-1 strain at the restrictive temperature (data not
shown). These results suggest that Pca1 turnover in the absence of cadmium occurs either
at the plasma membrane or before sorting to the plasma membrane.
3.4.3. Pca1 Degradation Is Dependent on the Proteasome But Not Vacuolar
Proteases. Plasma membrane proteins can be directly sorted to the vacuole for
degradation. For instance the Gap1 amino acid permease is directly targeted to the
vacuole when preferred nitrogen sources are available (42). Perhaps, in an analogous
manner Pca1 may sense cadmium before trafficking to the plasma membrane or is
otherwise degraded by the vacuole. To test this, we examined localization and turnover
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rate of Pca1 in a Δpep4 strain that is deficient in vacuolar protease activity (43). GFPPca1 did not accumulate in the vacuole of the Δpep4 strain, which was distinct from
Fet3-GFP, a cell surface iron oxidase, previously shown to undergo vacuolar degradation
(44) (data not shown). A cycloheximide chase confirmed that Pca1 undergoes
degradation at a similar rate in the Δpep4 background compared to an isogenic wild-type
strain (Fig. 3.2B), suggesting no significant role for vacuolar proteases in degradation of
Pca1. The dependence of Pca1 degradation through the vacuolar/endosomal pathway
was further examined in a Δvps4 null mutant, which is defective in both anterograde (late
endosome-to-vacuole) and retrograde (late endosome-to-Golgi) trafficking. Resident
proteins

of

the

late

endosome

are

typically

trapped

in

pre-vacuolar

compartments/multivesicular bodies in vps4 mutants. As shown in figure 3.2C, GFP-Pca1
does not accumulate in such compartments, unlike Fet4-GFP. We conclude that Pca1
degradation is not dependent on the vacuolar degradation pathway.
Given that Pca1 turnover is not dependent on vacuolar proteases, we questioned
whether the rapid degradation of Pca1 was dependent upon the proteasome. Indeed,
treatment of cells with the protease inhibitor MG132 led to a significant increase in Pca1
expression compared to vehicle-treated controls (Fig. 3.2D). This experiment was
performed in a Δpdr5 strain, previously shown to limit the efflux of protease inhibitors
(34). We also examined the steady state expression of Pca1 in a pre1-1 pre2-1 double
mutant, which is defective in proteasomal activity (33). Consistently, Pca1 is stabilized in
this strain although to a much lesser extent, which is likely due to some remaining
proteolytic activities in the pre1-1pre2-1 strain that participates in Pca1 degradation (Fig.
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3.2D).

Consistent to the fact that ubiquitination is a pre-requisite for proteasomal

targeting, ubiquitination of Pca1 was readily detectible (absence of ubiquitin ladder (Fig.
3.2F). However, it is diminished to non-detectable levels after cells are exposed to
cadmium (Fig. 3.2F). This observation hints toward a mechanistic explanation for
cadmium’s role in preventing the degradation of its own exporter. Rsp5 is an E3
ubiquitin-protein ligase that is known to be involved in regulation of several plasma
membrane proteins, such as metal dependent down regulation of the Znt1 zinc transporter
and Smf1 manganese transporter (40). However, an Rsp5-deficient strain did not stabilize
Pca1 (data not shown), suggesting no role for this ubiquitin-protein ligase in Pca1
turnover.
To exclude the possibility that stabilization of Pca1 by cadmium may reflect toxic
effects of cadmium on the cellular systems for ubiquitination and proteasomal
degradation, we tested the effects of cadmium on the expression of GFP-CL1 that has
been utilized as a reporter for determining the activities of the ubiquitination-proteasome
pathway (45). As shown in Fig. 3.2G, cadmium exposure at the same concentrations that
markedly stabilize Pca1 (Fig. 3.1E) had no significant influence on the expression levels
of GFP-CL1. Thus, cadmium’s inhibition of proteasomal degradation of Pca1 is specific.
Our previous data also showed that Pca1 protein expression is enhanced when yeast cells
are exposed to cadmium as low as 1 μM concentrations (30) which are similar to those
found in plants where natural yeast cells grow (6).
3.4.4. The Cysteine-rich Cytosolic Extension Contains a Degradation Signal.
We postulated that Pca1’s cysteine-rich N-terminal extension might contain a metal-
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Figure 3.2. Proteasome-dependent degradation of Pca1 and prevention of
ubiquitination by cadmium. A, Cycloheximide chase and Western blotting of HAPca1 expressed in end4-1 strain and isogenic parental strain (WT). Cells were
cultured at 37 oC to block endocytosis and collected at the indicated time points for
Western blot analysis. B, Cycloheximide chase of HA-Pca1 expressed in Δpep4 strain
and isogenic parental (WT) strain. C, Confocal imaging of GFP-Pca1 or Fet4-GFP
expressed in Δvps4 or isogenic parental strain. D, Empty vector or HA-Pca1 was
expressed in Δpdr5 cells in which proteasome inhibitor efflux is reduced (34). Cells
were cultured in the presence (+) or absence (-) of proteasome inhibitor MG132 (40
µM, 5 hrs). Total protein extracts were subject to Western blot analysis using anti-HA
antibodies. E, HA-Pca1 was expressed in a temperature-sensitive pre1-1pre2-1
proteasome defective mutant or isogenic parental strain (WT) at restrictive
temperature (37oC) for two hours. Relative expression of HA-Pca1 was detected by
anti-HA immunoblotting. F, Cadmium inhibits Pca1 ubiquitination. Cells expressing
HA-Pca1 were cultured with (+) or without (-) cadmium (50 μM CdCl2, 2 hrs). HAPca1 in total protein extracts was immunoprecipitated with beads conjugated with
anti-HA antibodies. HA-Pca1 and ubiquitin-attached HA-Pca1 were detected by
immunoblotting using anti-ubiquitin (Ub) and anti-HA antibodies. Arrow indicates
the expected migration of non-ubiquitinated HA-Pca1. G, Cadmium does not stabilize
a model substrate of the ubiquitination-proteasome degradation pathway. Expression
responding degradation signal. Indeed, while full-length Pca1 is hardly detectable in the
levels of GFP-CL1 were detected in cells pre-cultured for 1 hr without (NT) or with
cadmium (50 μM CdCl2). Cycloheximide (100µg/mL) was added to the culture media
after collection of time zero. Total protein extracts prepared from cells collected at the
indicated time points were subject to Western blot analysis using anti-GFP antibodies.
PGK was probed to determine equal loading.
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absence of copper or cadmium, deletion of this domain (Pca1Δ392) resulted in
constitutive expression at the cell surface even in the absence of cadmium (Fig. 3.3A and
3.3B). These data strongly suggest that Pca1 turnover occurs via this domain. Consistent
with the idea that Pca1 ubiquitination is dependent on a degradation signal within the Nterminal domain, ubiquitination was not detected in Pca1Δ392 (Fig. 3.3C). While the
Pca1(1-392) domain is necessary for Pca1 turnover, co-expression of this domain with
Pca1Δ392 separately did not lead to enhanced turnover of Pca1Δ392 (data not shown).
This suggests that in order to serve as a degradation signal for Pca1 this domain should be
associated with the entire protein.
To determine whether the N-terminal regulatory domain is sufficient for
controlling the expression of another plasma membrane transporter, we fused the peptide
comprising amino acid residues 1 to 392 of Pca1 to the N-terminus of a coppertransporting P1B-type ATPase (CaCRP) identified from C. albicans (46,47) and then
expressed in S. cerevisiae. The Pca1(1-392)-CaCRP fusion was fully functional in
conferring copper tolerance to yeast cells indicating correct folding and trafficking (Fig.
3.4A). Confocal microscopy (Fig. 3.4B) and Western blot analysis (Fig. 3.4C)
demonstrated that residues 1 to 392 in Pca1 control CaCRP expression specifically in a
cadmium and copper dependent manner. Hence, this domain functions as an autonomous
degradation signal that can be masked when cells are growing in media supplemented
with cadmium or copper.
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Figure 3.3. The cysteine-rich N-terminus of Pca1 contains a degradation signal.
A, Metal-dependent expression of GFP-Pca1 or GFP-Pca1Δ392. Cells expressing
GFP-Pca1 or GFP-Pca1Δ392 were cultured in the absence (NT) or presence of metal
ions (50 μM CuCl2, 50 μM CdCl2, or 15 mM ZnCl2 for 1 hr). GFP fluorescence in
cells was visualized by confocal microscopy. Copper sensitive Δace1 strain (24) was
used for these experiments presented in both A and B. B, Western blotting of GFPPca1 and GFP-Pca1Δ392 in cells cultured with (+) or without (-) cadmium (50 μM
CdCl2 for 2 hrs) using anti-GFP antibodies. Asterisk indicates non-specific bands. Top
arrow indicates full-length GFP-Pca1 and bottom arrow indicates GFP-Pca1Δ392. C,
Ubiquitination of Pca1 is dependent on the N-terminal domain. HA-Pca1 and HAPca1Δ392 were immunoprecipitated and then detected by Western blotting using antiubiquitin (Ub) and anti-HA antibodies.
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Figure 3.4. The N-terminal cytosolic extension of Pca1 is an auto-regulatory
domain that can be masked by cadmium and copper. A, Yeast cells expressing
GFP-tagged wild-type CaCRP or CaCRP fused with the first 392 amino acids of the
N-terminus of Pca1 (Pca1(1-392)) were spotted on solid media containing toxic
copper (CuCl2, 0.1 mM). B, Expression of GFP-CaCRP and GFP-Pca1(1-392)CaCRP in cells cultured with CuCl2 or CdCl2 (50 μM, 2 hrs) were determined by
visualization of GFP fluorescence with confocal microscopy. C, Western blot
analysis of cells cultured as described above (B) using anti-GFP antibodies. A
copper sensitive Δace1 strain (24) was used for these experiments.
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We aligned this domain with characterized P1B-type ATPases and other proteins.
However, the Pca1 N-terminal domain does not possess any significant sequence
similarity to known proteins. Therefore, we employed a mapping strategy to define a
signal sequence of metal-dependent degradation. Serial deletions of the N-terminus and
fusion of various Pca1 N-terminal fragments to CaCRP were made (Fig. 3.5A) and then
expressed in yeast cells. Characterization of expression levels and metal-dependent
stabilization using confocal microscopy revealed that a region encompassing residues 250
to 350 (Pca1(250-350)) is necessary and sufficient for both rapid turnover and cadmium
or copper- dependent stabilization (Fig. 3.5A and 3.5B). Since the Pca1(250-350)
degradation signal likely interacts with cellular factor(s) necessary for Pca1 degradation,
we hypothesized that excess expression of this domain would compete for degradation of
full-length Pca1. Indeed, co-expression of the Pca1(250-350) peptide with Pca1 leads to
enhanced expression of Pca1 (Fig. 3.5C). Collectively, these data indicate that this
Pca1(250-350) contains a degradation signal that can be masked by metal sensing.
3.4.5. Cysteine Residues within the Pca1 Regulatory Domain Are Required
for Metal Sensing. This 250-350 amino acid peptide contains seven cysteine residues
(Fig. 3.6A). Given that cysteine is a known metal ligand, we predicted metal ion binding
to this domain. A Pca1(250-350) peptide tagged with three tandem copies of HA epitope
(HA-Pca1(250-350)) was expressed in Δace1 or Δycf1 strains that are sensitive to copper
or cadmium, respectively (24,25). We hypothesized that this peptide would bind and
sequester metal ions like metallothionein (20), which would confer resistance to copper
and cadmium. Growth assays on media containing copper or cadmium at toxic levels
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Figure 3.5. The N-terminal domain encompassing amino acids 250 to 350 is
necessary and sufficient for the control of Pca1 and CaCRP expression in a
metal-dependent manner. A, Pca1 with or without N-terminal truncations and
Pca1 N-terminal fragments fused with CaCRP were expressed in yeast. A GFP
was tagged in frame at the N-terminus of these expression constructs for
visualization. Steady state GFP fluorescence in cells growing exponentially was
scored as weak (-) or strong (+) by confocal microscopy. Cadmium (50 μM
CdCl2 for 2 hrs) dependent enhancement (+) of GFP fluorescence was
determined. B, Confocal microscopy of GFP-Pca1(250-350)-CaCRP fusion in
cells cultured in the absence (NT) or presence of metals (50 μM CuCl2 or CdCl2
for 2 hrs). C, Determination of HA-Pca1 expression levels in cells with (+) or
without (-) co-expression of the Pca1(250-350) peptide. HA-Pca1 was detected
by immunoblotting with anti-HA antibodies. PGK in the same blot was probed
as a loading control. A copper sensitive Δace1 strain (24) was used for these
experiments.

94
showed that cells expressing HA-Pca1(250-350) displayed cadmium and copper
resistance compared with empty vector transformed cells (Fig. 3.6B). However, this
peptide did not confer zinc tolerance in a zinc-sensitive strain (data not shown). These
data are in accordance with that both cadmium and copper, but not zinc, stabilized Pca1
(Fig. 3.3A) and CaCRP fused with this regulatory domain (data not shown). The same
peptide in which all cysteine residues are substituted to alanine (ΔCys), did not confer
metal resistance (Fig. 3.6B), supporting roles for cysteine residues in metal binding. To
ensure equal or greater levels relative to the wild-type peptide (Fig. 3.6D), we expressed
HA-Pca1(250-350)ΔCys peptide using a high-copy plasmid.
We next examined which cysteine residues within this domain play roles for
conferring resistance to cadmium and/or copper. Site-directed mutation of the CxC motif
(C298A, C300A) abolished copper resistance but not cadmium resistance (Fig. 3.6C).
Conversely, mutation of the CC motif (C311A, C312A) abolished cadmium resistance
yet retained the ability to confer copper resistance (Fig. 3.6C). These data support distinct
roles for these cysteine residues in copper or cadmium coordination.
We predicted that cysteine mutations would compromise metal-dependent
masking of the degradation signal. Indeed, cadmium or copper could not stabilize CaCRP
fused with HA epitope-tagged Pca1(250-350) where all seven cysteine residues were
substituted to alanine (ΔCys) (Fig. 3.6E upper panel, fifth and sixth lanes). However,
steady state expression levels without metal addition to culture media (NT) were not
significantly different between control (WT) and cysteine mutant (ΔCys) (Fig. 3.6E upper
panel, first lane versus fourth lane) suggesting that cysteine residues are specifically
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necessary for cadmium or copper-induced stabilization but not turnover. Collectively,
these data suggest that cysteine-based metal sensing within a cis-acting degradation
signal serves as a molecular switch for rapid up-regulation of Pca1.

Figure 3.6. Cysteine residues within the regulatory domain of Pca1 are required
for metal sensing. A, Sequence of a metal-responsive degradation signal
encompassing amino acids 250 to 350 in the N-terminus of Pca1. Seven cysteine (C)
residues are in boldface. C298, C300, C311, and C312 are underlined. B, Empty vector
(V), a single-copy expression vector of N-terminal triple HA-tagged Pca1(250-350)
(HA-Pca1(250-350), WT), and a multi-copy expression vector of HA-Pca1(250-350)
with substitution of all seven cysteine residues to alanine (ΔCys) were transformed into
copper sensitive Δace1 (24) and cadmium sensitive Δycf1 (25) strains. Cells growing
exponentially were spotted on SC media without (NT) or with supplementation of toxic
copper or cadmium (50 μM CuCl2 or CdCl2). Cell growth was assayed after two days.
C, Empty vector (V) and an expression vector of HA-Pca1(250-350) possessing
specific cysteine mutations as indicated were transformed into cells. Cell growth was
determined as described above (B). D, Western blotting of the HA-Pca1(250-350)
peptides in total protein extracts of cells described above (B) with anti-HA antibodies.
PGK was detected to determine equal loading. E, CaCRP fused with HA-Pca1(250350) at the N-terminus without (WT) or with site-directed mutagenesis of all seven
cysteine residues to alanine (ΔCys) were expressed in a Δace1 strain. Total protein
extracts of cells cultured without (NT) or with copper or cadmium (20 μM CuCl2 or
CdCl2 for 1 hr) were subject to Western blot analysis using anti-HA and anti-PGK
antibodies.
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3.5. Discussion
Our data reveal a new mode of expressional control of a metal-transporting P1Btype ATPase. In the absence of cadmium, Pca1 is rapidly targeted for degradation at the
proteasome via an N-terminal degradation signal. However, cadmium sensing allows
Pca1 to circumvent degradation, which is likely attributed to conformational changes
within the degradation signal induced by metal binding. Hence, cells are able to rapidly
express Pca1 at the cell surface only when Pca1 is required for cadmium efflux.
Since cadmium is extremely toxic and cadmium levels in the environment
fluctuate, transcriptional or translational regulation of a cadmium detoxification system
may not be fast enough for cell protection. The constant synthesis of Pca1 would be an
obvious advantage in coping with this problem. The underlying reason for rapid
degradation of Pca1 could be explained by the fact that Pca1 expression is not necessary
when cells are growing without cadmium stress. However, other factors may be
important for keeping Pca1 levels at a minimum. For example, Pca1 could play another
role other than cadmium efflux (e.g., efflux of nutritional metals), which would be
deleterious in the absence of cadmium. Indeed, it was shown that cells over-expressing
Pca1 grow slowly (48). If Pca1 transports nutritional metal ions due to broad substrate
specificity, as shown for several other metal-transporting P-type ATPases (26-28),
expression of Pca1 only when cadmium is in excess could prevent loss of essential metals
that are limiting for growth. While our previous data showed that Pca1 does not change
cellular accumulation of zinc, manganese, cobalt, or iron (30), Pca1 may transport these
or other metal ions under specific growth conditions. Secondly, it is not known what
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form(s) of cadmium and other metals are substrates of P1B-type ATPases. Ycf1, a
vacuolar cadmium ABC transporter in yeast, transports both glutathione-conjugated
cadmium and glutathione itself (25,49). A recent report showed that cysteine dramatically
increases the activities of CopA, ZntA and HMA2 P1B-type ATPases (50). Pca1 may
extrude cysteine, glutathione, or other ions such as sulfur with or without conjugation of
cadmium. If so, constitutive extrusion of these cellular factors would be deleterious, since
they are critical for redox homeostasis and metabolism (51,52). Alternatively, cysteine or
other cytosolic molecules may activate Pca1 as shown for ZntA and HMA2 (50),
resulting in constitutive ATP hydrolysis in the absence of cadmium.
Internalization followed by degradation at the vacuole is a major pathway for
turnover of plasma membrane proteins. For example, Zrt1 zinc transporter, Fet3/Ftr1 iron
transporter complex, and Smf1 manganese transporter are subject to this mode of
posttranslational regulation (40,44,53,54). Given that these transporters play roles in
metal ion uptake, they are down regulated when cells are exposed to excess metal ions.
Substrate-dependent ubiquitination of membrane transporters is often a signal that
triggers turnover of these transporters (40). However, Pca1 regulation by cadmium is
unique when compared with these other metal ion transporters in that it is rapidly upregulated by cadmium-mediated rescuing from degradation. Moreover, degradation of
Pca1 occurs at the proteasome in an endocytosis-independent manner. It is interesting to
note that cellular trafficking of Arn1, a transporter of an iron-siderophore complex, is
regulated by its substrate at several steps. Substrate sensing triggers plasma membrane
sorting of Arn1, and its cycling between the plasma membrane and endosomes is induced
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by substrate binding at the cell surface (55,56). Pca1 sorting to the cell surface versus
degradation at the proteasome may be controlled by a similar mechanism as characterized
for Arn1. We are currently pursuing the identification of molecular factors that are
involved in Pca1 turnover and the subcellular compartments where cells determine the
fate of Pca1.
Most P1B-type ATPases possess N-terminal metal binding domains (MBDs) that
are thought to play roles in catalysis and/or regulation. The conserved MBD (~70 amino
acids, βαββαβ fold) contains a GMXCXXC sequence in which two cysteine residues
coordinate a metal ion (3,29). While this domain is conserved in many P1B-type ATPases,
the numbers of it vary, ranging from one to six. The N-terminus of Pca1 contains only
one conserved MBD in which two cysteine residues are essential for function (30).
Human copper transporting ATPases possess six MBDs at the N-terminus. The Atx1
metallochaperone delivers copper through direct docking to MDBs with different
preferences among them (57-59), suggesting distinct functions of these domains. The
structure and metal coordination of MBDs are relatively well characterized; however, the
roles for these domains in ATPase function are not yet clear. Copper binding was initially
proposed as a substrate recognition step followed by transfer of metal to the translocation
pore. However, site-directed mutagenesis and deletion of MBDs suggest a regulatory
role. For example, the 5th or 6th MDB of human ATP7a is necessary and sufficient for
copper-induced redistribution (60). An inhibitory role of the N-terminus of a copper
transporting ATPase has been proposed as well (61). Interestingly, a recent report (62)
suggested the presence of either additional regulatory copper-binding site(s) within the
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protein or another unknown mechanism for copper sensing. Collectively, while
significant progress in the characterization of conserved MBDs in N-terminus of P1B-type
ATPases has been made, the functional roles of these domains remain elusive.
We have identified a distinct MBD in the N-terminus of Pca1 that is necessary for
extremely efficient control of Pca1 expression in response to cadmium. Several atypical
MBDs have been identified in other P1B-type ATPases as well. The core sequence of Nterminal MBD’s of A. thaliana HMA2-4 is substituted by a degenerate sequence,
GICC(T/S)SE (63). HMA2 and HMA4 zinc ATPases possess C-terminal MBDs (several
di-cysteine pairs and an eleven histidine stretch) that regulate enzyme activities (63,64).
A CHHC predicted metal binding sequence was identified at the C-terminus of the CopA
copper ATPase in Archaeoglobus fulgidus (65). The histidine-rich N-terminal metal
binding domain of the CopB copper ATPase in A. fulgidus appears to have a regulatory
role affecting metal transport rates by controlling metal release (66). In addition to heavy
metal-transporting P1B-type ATPases, it was also shown that Ca2+-transporting P-type
ATPases carry inhibitory domains (67). Cytosolic regulators and phosphorylation of Cterminal residues control activities of H+-transporting ATPases in plants (68). Hence,
auto-regulatory mechanisms may be widespread in P-type ATPases.
We propose that direct metal binding to the Pca1(250-350) domain induces
conformational changes that would mask a signal recognized by the protein degradation
machinery. Expression of Pca1(250-350) itself confers both cadmium and copper
tolerance, which supports the conclusion that this domain directly binds metals.
Substitution of cysteine residues within this domain abolished metal resistance suggesting
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a role for cysteines in metal coordination. Site-directed mutation of cysteine residues
suggests that binding site(s) of cadmium and copper do not overlap directly. Given that
Pca1 does not transport copper (30), the physiological significance of the stabilization of
Pca1 by copper is not obvious at this moment. It is necessary to point out that in a
copper-sensitive Δace1 strain Pca1 stabilization by copper is observed at similar
concentrations to that of cadmium; however, in wild-type cells relatively high copper
concentration (~2 mM) is necessary for Pca1 stabilization (data not shown). CUP1 and
CRS5-encoded metal chelators that are up-regulated by Ace1 likely have higher affinity
to copper than the N-terminus of Pca1.
Fusion of the Pca1(250-350) domain with a stable protein leads to a rapid
turnover and metal-dependent stabilization, demonstrating a role as a autonomous and
metal-responsive degradation signal. However, this domain does not carry significant
sequence identity with characterized degradation signals or known proteins. Given that
Pca1(250-350) is located in the middle of the N-terminus, the N-end rule pathway of
protein degradation is unlikely involved in Pca1 degradation (69). Pro, Glu, Ser, and Thr
amino acid enriched sequence (PEST sequence) is a proteolytic signal (70). However,
Pca1 250-350 is not predicted to contain a PEST signal (https;//embl.bcc.univie.ac.at/). It
has been proposed that exposure of hydrophobic residues could recruit molecular
chaperones, which results in re-folding to a functional protein or targeting for
degradation. Structural characterization of this domain in apo and cadmium-bound forms
would reveal what characteristics lead to degradation of Pca1 and how metal binding
masks this degradation signal. We are currently pursuing characterizations of structure
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and metal binding of this domain in detail; however, purification of ample quantities of
the Pca1(250-350) peptide has been a technical challenge (Adle and Lee, unpublished
data).
It is interesting to note that the N-terminus of a human copper ATPase interacts
with several proteins, although the physiological significance of these interactions
remains to be elucidated. For example, MURR1/COMMD1 binds with the N-terminus of
ATP7b, which decreases stability of newly synthesized ATP7b (71). A hepatocytic
isoform of PLZF (promyelocytic leukemia zinc finger) protein interacts with the Cterminus of ATP7b, which positively regulates ERK signal transduction (72).
Glutaredoxin interacts with the N-terminus of ATP7a and ATP7b (76), and the dynactin
subunit p62 interacts with the N-terminus of ATP7b (73). These protein-protein
interactions may play critical roles for the function, regulation of catalytic activities,
and/or subcellular trafficking of ATP7b and possibly other P1B-type ATPases. The
regulatory domain identified at the N-terminus of Pca1 may interact with accessory
protein(s) that target Pca1 to the ubiquitin-proteasome pathway.
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Chapter 4

Cadmium-mediated rescue from ER-associated degradation
induces expression of its exporter
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4.1. Abstract
Cadmium is a highly toxic environmental contaminant implicated in various
disorders. A major mechanism for cadmium detoxification in yeast Saccharomyces
cerevisiae relies on extrusion via Pca1, a P-type ATPase. While an N-terminal degron
targets Pca1 for degradation before its secretion to the plasma membrane, cadmium in the
growth media rapidly up regulates Pca1 by preventing its turnover. Here we show that the
endoplasmic reticulum-associated degradation (ERAD) system, known for its role in
protein quality control of secretory proteins, is unexpectedly responsible for the
regulation of Pca1 expression by cadmium. Direct cadmium sensing at the ER leads to
conformational changes of this degron, which suggests how recognition of Pca1 for
ERAD is prevented. This regulated conversion of an ERAD substrate to a secretory
competent state in response to a cellular need illustrates a novel mechanism for
expressional control of a plasma membrane protein. Yeast has likely evolved this mode
of regulation for a rapid response against cadmium toxicity at the expense of constant
synthesis and degradation of Pca1. ERAD of a portion of secretory proteins might occur
via signal-dependent regulatory mechanisms as demonstrated for Pca1.
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4.2. Introduction
Metal ions are highly toxic, although several metals such as iron, copper and zinc
are essential micronutrients. Organisms possess delicate systems for detoxification and
excretion of nonphysiological metals and homeostatic metabolism of nutritional yet toxic
metals (1,2). Pca1 in S. cerevisiae is a multi-spanning transmembrane protein that
belongs to the family of P1B-type ATPase heavy metal transporters widely distributed
from bacteria to humans (3). Pca1 functions in the efflux of cadmium across the plasma
membrane (4), an extremely toxic environmental pollutant that causes various human
diseases, such as cancer, kidney disease and endocrine disruption (5).
We have previously demonstrated that Pca1 is a short-lived protein that is targeted
for ubiquitination and proteasomal degradation before reaching the cell surface (6).
However, in the presence of cadmium, Pca1 is rapidly up regulated due to the prevention
of its degradation (6). An autonomous degron encompassing amino acid residues 250-350
within the N-terminal cytosolic domain is necessary and sufficient for both degradation
and metal sensing (6). Given that the cell surface expression of several plasma membrane
proteins is regulated by ubiquitin-mediated endocytosis followed by vacuolar
degradation, Pca1 turnover and cadmium-responsive degradation represents an
interesting mode of expressional control in which subcellular trafficking and stability are
determined by its substrate during secretion.
To uncover molecular factors involved in the expressional control of Pca1, we
have devised a genetic screen to identify mutants that are defective in Pca1 degradation in
the absence of cadmium. Unexpectedly, our data presented herein demonstrate that
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components of the ER associated degradation (ERAD) system target Pca1 for
proteasomal degradation.
Secretory proteins in eukaryotes are inserted into the ER lumen or membrane
where correct folding and maturation occurs. Numerous factors, such as molecular
chaperones, glycosylation enzymes, and protein disulfide isomerases, are involved in this
process. Genetic mutations and environmental stresses (e.g., heat, oxidative stress)
enhance the probability of failure of protein folding and maturation. The unfolded protein
response (UPR) pathway enhances the capability of protein folding when cells are
challenged by these stresses (7). The ERAD system eliminates terminally misfolded or
unassembled proteins, which is critical for the prevention of toxic accumulation of
aberrant proteins (8, 9). Several mutant proteins, unassembled subunits of secretory
proteins, and heterologously expressed proteins have all been identified as ERAD
substrates (8, 9). However, Pca1 is a naturally expressed and functional protein and there
is no evidence of multimer assembly for pca1.
Cadmium is extremely toxic and its levels fluctuate in the environment. Thus,
transcriptional and/or translational control of defense factors may not be fast enough for
cell protection. Our results suggest that yeast cells have evolved to harness the ERAD
system for rapid up-regulation of Pca1 cell surface expression by direct sensing of
intracellular cadmium at the ER.
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4.3.

Experimental Procedures
4.3.1. Yeast strains, media and growth conditions. Yeast strains used in this

study are listed in Table 4S1. Most strains are from the Saccharomyces Genome Deletion
Project (10) which was purchased from Open Biosystems. Double knockouts were
generated by PCR-based gene deletion using pFA6a-His3MX6 as a template for
homologous recombination (11). Diagnostic PCR using gene-specific primer sets
confirmed correct replacement of target genes by the His3MX6 cassette. Yeast cells were
cultured in YPD or synthetic complete (SC) media as previously described (4).
4.3.2. Construction of expression plasmids and transformation. A single copy
yeast vector was used for glyceraldehyde-3-phosphate dehydrogenase (GPD) gene
promoter-mediated constitutive expression unless specified (12). For the generation of
expression plasmids of green fluorescent protein (GFP) or triple hemagglutinin (HA)
epitope-fusion proteins, NotI restriction enzyme site-flanked GFP or three tandem HA
epitopes were inserted into a NotI site artificially generated at the N or C-terminal end. A
plasmid containing four tandem copies of the 22bp Unfolded Protein Response Element
(UPRE) inserted upstream of a disabled CYC1 promoter lacZ gene fusion (13) was
kindly provided by Dr. Peter Walter (University of California, School of Medicine, San
Francisco, California). A Ste6* expression plasmid (14) was generously provided by Dr.
Susan Michaelis (John Hopkins School of Medicine, Baltimore, Maryland). Site-directed
mutagenesis was conducted by the primer overlap extension method (15). Plasmids were
transformed into yeast using the lithium acetate procedure (16). Yeast cells were grown at
30°C on synthetic complete (SC) media for plasmid selection.
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Table 4S.1. Yeast Saccharomyces cerevisiae strains used in this study.

Strain

Genotype

Reference

BY4741

MATa his3∆1 leu2∆0 met15∆0 ura3∆0

Open Biosystems

BY4741 Δcue1

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 cue1::KanMX

Open Biosystems

BY4741 Δdoa10

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 doa10::KanMX

Open Biosystems

BY4741 Δhrd1

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hrd1::KanMX

Open Biosystems

BY4741Δhrd1 Δdoa10

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hrd1::KanMX doa10::HIS3

This study

BY4741 Δubc6

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ubc6::HIS3

(42)

BY4741 Δubc7

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ubc7::KanMX

Open Biosystems

BY4741 Δubc6 Δubc7

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ubc6::HIS3 ubc7::NatMX

(42)

SEC23

MATα ura3-52 leu2-3,-112

(25)

sec23-1

MATα ura3-52 his4-619 sec23-1

(25)

CDC48

MATa ura3-52 his3∆200 leu2∆1 trp∆63

(43)

cdc48-1

MATa ura3-52 his3∆200 leu2∆1 trp∆63 cdc48-3

(43)

W303-1b

MATα ade2 his3 leu2 ura3 trp1 can1-100

(19)

KNY111

MATα ade2 his3 leu2 ura3 trp1 can1-100 DOA10-13MYC-KANMX

(19)

114
4.3.3. Selection of yeast mutants constitutively expressing Pca1. A functional
Pca1 fused with green fluorescent protein (GFP) at the N-terminus was expressed in a
yeast S. cerevisiae deletion pool (Open Biosystems) containing individual deletions of all
nonessential genes. Highly fluorescent cells (top 1% among the collected ~400,000
transformants) were sorted by flow cytometry. Positive candidates were confirmed by
confocal microscopy and gene knockouts were identified using specific primer sets for
PCR amplification and sequencing of a unique 20 base “tag” sequence (10).
4.3.4. Preparation of cell extracts and immunoblotting. All immunoblotting
was performed essentially as described previously (4). Briefly, total protein extracts were
prepared by vortexing yeast cells with glass beads in PBS containing protease inhibitor
cocktail (Complete Mini) (Roche) and 1% triton X-100. Lysates were denatured in SDS
sample buffer containing 25mM DTT for 15min at 37°C and resolved by SDS-PAGE
prior to transfer to nitrocellulose membrane and antibody probing.
4.3.5. Cycloheximide chase analysis. Protein synthesis was inhibited by the
addition of 100 µg/mL cycloheximide to logarithmically growing cultures. Cells
(A600=15) were collected into equal volumes of ice-cold kill buffer (PBS containing 15
mM NaN3) at the indicated time points. For zero time points, cells were collected before
addition of cycloheximide. Cells were pelleted by centrifugation and stored at -80°C until
preparation of cell extracts for SDS-PAGE and immunoblotting (6). Pca1 was detected
by chemiluminescence using anti-HA antibodies and horseradish peroxidase (HRP)conjugated anti-rabbit IgG antibodies. Phosphoglycerate kinase (PGK) was probed as a
loading control using anti-PGK antibodies and HRP-conjugated anti-mouse IgG
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antibodies. Signals were quantified using Total Lab TL100 software and were normalized
to PGK.
4.3.6. 64Cu blotting and autoradiography. Hemagglutinin (HA) epitope-tagged
Pca1(250-350) or Pca1(250-350)ΔCys where all cysteine residues were mutated to
alanine were immunoprecipitated from Δdoa10 cell lysates using anti-HA antibodyconjugated beads (Pierce). Samples were subjected to SDS-PAGE and electroblotted onto
a nitrocellulose membrane. Membranes were equilibrated in metal binding buffer (17),
probed with ~10 μCi of 64Cu (~1µM CuCl2) (Isotrace Technique) for 1hr, and then
washed extensively prior to autoradiography and protein staining (MemCode) (Pierce).
Competition with 64Cu binding was determined in the presence of 5-fold excess of nonradioactive competitor ions.
4.3.7. Limited trypsin proteolysis of Pca1(250-350). Cytosolic fractions were
obtained from Δdoa10 cells expressing triple HA epitope-tagged Pca1(250-350) or
Pca1(250-350)ΔCys cultured with or without cadmium (50µM CdCl2, 1hr). Lysates were
incubated with trypsin (Sigma) for 10min on ice before addition of 0.2µg/mL soybean
trypsin inhibitor (Fluka BioChemika) for an additional 15min on ice. Proteolysis patterns
were visualized by anti-HA immunoblotting.
4.3.8. β-Galactosidase reporter assay. Cells were assayed for β-galactosidase
expression as described previously (18). Briefly, cells (A600=1) were permeabilized with
chloroform and 0.1% SDS in 1mL of Z buffer and incubated with 0.2 mL of 4 mg/mL
ONPG (ortho-Nitrophenyl-β-galactoside) dissolved in Z buffer. Reactions were quenched
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by adding 0.5 mL of Na2CO3. β-Galactosidase levels were converted to Miller units
[(A420)/(Tmin)(VmL)(A600)].
4.3.9. Microsome preparation and chemical cross-linking. Microsome
preparation was performed as previously described with modifications (19). Cells
(A600=30) were disrupted by glass bead vortexing in 300µL lysis buffer (20mM 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 50mM potassium acetate
(KoAc), 2mM ethylenediaminetetraacetic acid (EDTA), 0.1M sorbitol, 1mM
dithiothreitol (DTT), 1mM phenylmethanesulphonylfluoride (PMSF) and HALT protease
inhibitor cocktail (Pierce) for ten 30sec intervals alternating with incubation on ice. An
additional 250µL buffer 88 (20mM HEPES, 50mM KOAc, 250mM sorbitol and 5mM
magnesium acetate (MgOAc) was added. Unbroken cells and glass beads were cleared by
low speed centrifugation (3,000rpm for 5min) and then repeated with a second rinse with
buffer 88. The supernatant fractions were pooled and centrifuged 18,000g for 20min at
4°C. The supernatant was decanted and the final microsomal membrane pellet was
washed once and re-suspended in 150µL of 0.2M triethanolamine, pH 8.0 and incubated
on ice for 1hr with 100µg/mL dimethyl 3,3’-dithiobispropionimidate (DTBP) a water
soluble, membrane permeable and thiol reversible cross-linker. Cross-linking reactions
were quenched by addition of 40uL of 1M Tris (pH 7.5) and incubated on ice for an
additional 20min. Cell pellets were collected by centrifugation at 18,000g for 15min at
4°C and washed with 400µL PBS. For membrane solubilization, cell pellets were
resuspended in 100µL of 1% SDS in PBS and incubated at 37°C for 30min. Triton X-100
was added for a total concentration of 1.5% (400µL total volume) and incubated on ice
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for an additional 30min. From this lysate, HA-tagged proteins were immunoprecipitated
with anti-HA antibody-conjugated sepharose beads (Pierce) overnight at 4°C according to
manufacturer. Immobilized proteins were eluted with 2XSDS sample buffer at 37°C for
15min. Chemical cross-linking was reversed by incubation with 0.1M DTT for an
additional 15min at 37°C before SDS-PAGE and immunoblotting.
4.3.10. Oligomycin resistance assay. Wild type and Δdoa10 strains expressing
empty vector, Yor1-GFP or Pca1(1-392)-Yor1-GFP were cultured in SC selective media
to mid-log phase. Cells (~5 µL, A600=0.1) were spotted on solid YPEG media (2% BactoPeptone, 1% yeast extract, 2% ethanol, 3% glycerol and 1.5% agar), prepared with or
without the addition of cadmium (10µM CdCl2) and oligomycin (2.5µg/mL). Plates were
incubated at 30°C for two days before photography.
4.3.11. Immunoprecipitation and detection of ubiquitin. Cells were broken by
glass beads vortexing in PBS containing protease inhibitors (Complete Mini) (Roche),
5mM N-ethylmaleimide, 1mM PMSF and 1% Triton X-100. HA epitope tagged proteins
were immunoprecipitated with an HA-Tag IP/Co-IP kit (Pierce) according to
manufacturer specifications. Proteins were eluted by incubation of immobilized anti-HA
agarose beads in 2XSDS sample buffer at 37°C for 15min and reduced in the presence of
0.1M DTT for an additional 15min at 37°C. Ubiquitin conjugated proteins were detected
by immunoblotting using mouse monoclonal antibodies against ubiquitin (Covance).
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4.4. Results
4.4.1. Pca1 is targeted for ER-associated degradation in the absence of
cadmium. In order to identify molecular factors involved in Pca1 turnover, we selected
yeast mutants exhibiting defects in Pca1 degradation. An expression construct of a fully
functional Pca1 fused with green fluorescent protein (GFP-Pca1) was transformed into a
collection of mutant yeast strains, each lacking a single nonessential gene (10). Cells
emitting strong GFP signal (as a consequence of a defect in degradation of the GFP-Pca1
fusion) were selected using a flow cytometer, and gene deletions resulting in high Pca1
expression were identified (Fig. 4.S1A).
Unexpectedly, Pca1 is highly expressed in cells with deletions of the CUE1 gene
(Fig. 4.S1B and 4.S1C). CUE1 encodes an ER membrane-bound protein that recruits
Ubc7, a cytosolic ubiquitin-conjugating enzyme, to the ER surface (20). Given that Cue1
is a crucial factor involved in ERAD, we further examined Pca1 stabilization in yeast
strains bearing deletions in factors required for ERAD, including Ubc7 (21) and Ubc6
ubiquitin-conjugating enzymes (22), and ER resident Doa10 (23) and Hrd1 (24) ubiquitin
ligases. In yeast, the recognition of integral membrane ERAD substrates is governed by
the location of the misfolded domain. Lesions in soluble domains on the cytosolic face of
the ER belong to the ERAD-C (cytoplasmic pathway) in which their ubiquitination and
degradation are largely dependent on Doa10 (8,9). On the other hand, Hrd1 is involved in
ubiquitination and degradation of substrates with misfolded regions in soluble luminal
domains (ERAD-L) or within transmembrane domains (ERAD-M) (8,9). Pca1
stabilization was evident in Δubc7 or Δdoa10 but not Δhrd1 strains (Fig. 4.1A).
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Figure 4.S1. Genetic Screen conducted to identify factors involved in Pca1
degradation. A, Schematic of genetic screen strategy. B, Confocal
fluorescence microscopy of wildtype or Δcue1 cells expressing GFP-fused
Pca1. C, Western blot of HA-Pca1 expressed in Δcue1 background. PGK was
probed as a loading control.

Cycloheximide chase of HA-Pca1 further confirmed no significant role for Hrd1 in Pca1
turnover (Fig. 4.1B), indicating the specificity of Doa10 in Pca1 turnover. Consistent
with ubiquitination by this E3 ligase, Pca1 ubiquitination was dramatically reduced in the
Δdoa10 strain (Fig. 4.1C). Pca1 turnover was also decelerated in Δubc6 strain, but to a
lesser extent than in the Δubc7 strain (Fig. 4.S2). Collectively, these data indicated that in
the absence of its cadmium substrate, Pca1 was rapidly degraded through the ERAD
pathway. Given that we could only select CUE1 null mutants multiple times despite
several ERAD components are involved in Pca1 turnover, our selection of mutants was
not saturated.
4.4.2. Degradation of Pca1 and cadmium sensing occur at the ER. Given that
Pca1 degradation and ubiquitination required Doa10, an ER-resident ubiquitin ligase, we
reasoned that Pca1 degradation occurs before its secretion from the ER. To demonstrate
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Figure 4.1. Pca1 is degraded through the ERAD pathway. (A) Confocal
microscopy of GFP-fused Pca1 expressed in wildtype (WT), Δcue1, Δubc7,
Δdoa10 or Δhrd1 strains. (B) Cycloheximide chase and immunoblotting of HA
epitope tagged Pca1 (HA-Pca1) expressed in wildtype (WT), Δhrd1, Δdoa10 or
Δdoa10 Δhrd1 strains at the indicated time points. Each blot was probed for
phosphoglycerate kinase (PGK) to determine equal loading. For quantification,
pixel densities of HA-Pca1 were normalized to those of PGK. Average ±S.D. of
three independent experiments is graphed (lower panel). (C) Detection of
ubiquitin-conjugated Pca1. Immunoprecipitation of HA-Pca1 in wildtype (WT) or
Δdoa10 cells followed by Western blot with anti-Ub or HA antibodies. Arrow
indicates expected migration of HA-Pca1.
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Figure 4.S2. Roles for Ubc7 and Ubc6 ubiquitin conjugating enzymes in Pca1
turnover. (A) Cycloheximide chase and immunoblotting of HA epitope tagged
Pca1 expressed in wildtype (WT), Δubc6, Δubc7, or Δ ubc6 Δubc7 strains at the
indicated time points. Each blot was probed for phosphoglycerate kinase (PGK) to
determine equal loading. Representative data from three independent experiments
is shown. (B) For quantification, pixel densities of Pca1 were normalized to those
of PGK.

this hypothesis, we first examined the fate of Pca1 turnover in a sec23-1 mutant which
exhibits a temperature sensitive defect in COPII vesicle dependent ER to Golgi
trafficking (25). As shown in Fig. 4.2A, trapping Pca1 in the ER had no significant effect
on turnover rate, demonstrating that Pca1 degradation does not require its exit from the
ER. Second, we determined the stability of Pca1 in a temperature sensitive mutant of the
Cdc48/Np14p/Ufd1 AAA-ATPase, which is required for efficient ER extraction and
degradation of integral membrane ERAD-C substrates such as Ste6*, a mutant plasma
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membrane protein (26). Consistent with a role for Cdc48 in Pca1 turnover, stabilization
of Pca1 is apparent in the cdc48-3 strain compared to its isogenic wild-type strain at
restrictive temperature (Fig. 4.2B). Since Pca1 degradation occurs at the ER, it would be
intuitive that cadmium sensing which blocks degradation would also occur at the ER. As
expected, addition of cadmium to cell cultures prevented Pca1 degradation when ER exit
is blocked (Fig. 4.2C).

Figure 4.2. Pca1 degradation and cadmium sensing occur at the ER. (A) HAragged Pca1 was expressed in SEC23 and a sec23-1 temperature sensitive mutant.
To block ER to Golgi transport, cells were cultured at restrictive temperature
(37°C for 30min). After cycloheximide addition to culture media, cells were
collected at the indicated time points. Pca1 was detected by Western blotting using
anti-HA antibodies. (B) Cycloheximide chase and Western blotting of HA-Pca1
expressed in CDC48 and a cdc48-3 temperature sensitive mutant cultured at
restrictive temperature (37°C for 30min). (C) Cadmium enhances Pca1 expression
when ER to Golgi transport is blocked. A sec23-1 strain expressing HA-Pca1 was
cultured at restrictive temperature (37°C for 30min) prior to the addition of
cadmium (50µM CdCl2) for an additional 30min at restrictive temperature before
collection for immunoblotting. Each blot was probed for PGK to determine equal
loading.
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4.4.3. Inhibition of Pca1 ERAD by cadmium is specific. To confirm if the
inhibitory effect of cadmium on ERAD is specific to Pca1, we addressed possible toxic
effects of cadmium on ER functions, such as inhibition of ERAD machinery, or
saturation of ERAD capacity by excess accumulation of damaged and/or misfolded
proteins. Accumulation of misfolded proteins in the ER generally leads to induction of
the unfolded protein response (UPR) (27). The overall status of ER function was
monitored with a UPR reporter construct (UPRE-LacZ) (13). Despite being an ERAD
substrate, constitutive expression of Pca1 did not lead to any significant increase in
reporter gene expression over basal levels (Fig. 4.3A). Cadmium concentrations that
induce robust expression of Pca1 (Fig. 4.3B) led to a minimal UPR response (Fig. 4.3A),
whereas DTT strongly enhanced reporter levels (Fig. 4.3A) without affecting Pca1
expression (Fig. 4.3B). Furthermore, cadmium did not stabilize Ste6*, a well-studied
Doa10 substrate (Fig. 4.3C). Collectively, these data indicated that the cadmium
dependent stabilization of Pca1 is specific and was not due to over-accumulation of
misfolded protein intermediates or the inactivation of ERAD machinery.
4.4.4. The N-terminus of Pca1 contains a targeting signal for ERAD. Aberrant
secretory proteins typically engage quality control checkpoints, which prevents their exit
from the ER. For instance, when the ERAD pathway is inactivated, some substrates are
trapped in the ER rather than being secreted to the plasma membrane (26,28). We took
advantage of the ability of the Yor1 ATP-binding cassette (ABC) transporter to extrude
oligomycin, a mitochondrial toxin (29). If the Pca1 degron prevents ER exit, then Yor1
fused with this degron would be retained in the ER and no oligomycin resistance would
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Figure 4.3. Cadmium-dependent inhibition of Pca1 ERAD is specific. (A)
Unfolded protein response (UPR) determined by a UPRE-LacZ reporter construct
(13). Empty vector (-) or an expression construct of HA epitope tagged Pca1 (+)
was co-transformed with a UPRE-LacZ reporter construct in a wild-type (WT)
yeast strain. Cells were cultured in SC selective media with (+) or without (-)
supplementation of cadmium (Cd) (50µM CdCl2, 1hr). As a positive control of
UPR response, cells were cultured with DTT (2mM, 1hr) (13). Each bar represents
the average ± S.D. of β-galactosidase activities of four different samples. (B)
Western blot analysis of HA-Pca1 expressed in non-treated cells (NT) or cells
cultured in media supplemented with cadmium (Cd) (50µM CdCl2) or DTT
(2mM) for 1hr. (C) Western blot analysis of HA epitope tagged Ste6* in WT or
Δdoa10 cells cultured without (-) or with (+) supplementation of cadmium (Cd)
(50µM CdCl2, 1hr) to culture media. Each blot was PGK to determine equal
loading.

be conferred. Fusion of Pca1(1-392) converted the normally stable Yor1 transporter to an
unstable substrate which is stabilized by cadmium in culture media or deletion of DOA10
(Fig. 4.S3). Consistent with its rapid proteolysis, in the absence of cadmium the Pca1(1392)-Yor1-GFP fusion did not confer resistance to oligomycin (Fig. 4.4A, third row,
middle panel). However, upon supplementation of cadmium (Fig. 4.4A, third row, right
panel) or expression in a Δdoa10 strain, (Fig. 4.4A, fourth row, middle panel) the fusion
protein confers oligomycin resistance. These results demonstrate that the Pca1(1-392)Yor1-GFP fusion reaches the cell surface for oligomycin efflux when its degradation is
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Figure S4.3. Cadmium and Doa10 dependent regulation of Pca1(1-392)-Yor1GFP
Confocal fluorescent microscopy of Yor1-GFP and Pca1(1-392)-Yor1-GFP
expressed in a WT and Δdoa10 cells non-treated (NT) or with addition of
cadmium (50µM CdCl2, 1hr) .

prevented. Oligomycin resistance in the Δdoa10 strain expressing the Pca1(1-392)-Yor1GFP fusion without cadmium suggests that metal sensing is not a prerequisite for ER
exit. This is also in agreement with our previous observation where deletion of residues
1-392 did not perturb Pca1 trafficking or function (6).
We next examined whether the Pca1 degron can target a cytosolic protein for
ERAD. Our previous mapping of the Pca1 N-terminus identified a minimal region
encompassing amino acids 250-350 to be sufficient for rapid degradation (6). Expression
of a soluble GFP reporter C-terminally fused to Pca1 residues 250-350 (GFP-Pca1(250350)) was regulated in a cadmium and Doa10 dependent manner (Fig. 4.4B). However,
cadmium did not prevent turnover of GFP fused with CL1, an artificial Doa10 degron
(30) (Fig. 4.4B). These data indicate that the Pca1 degron can also target a cytosolic
protein for ERAD. We conclude that the Pca1 degron does not function as either an ER
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exit or retention signal but rather serves as a targeting signal for Doa10 dependent
ERAD.

Figure. 4.4. A degron in the N-terminus of Pca1 is not an ER retention
signal. A, Cell growth on media containing oligomycin. Cells (5µl of cells diluted to
A600= 0.1) were spotted on YPEG solid media that was made with (+) or without (-)
the addition of oligomycin (2.5µg/mL) and/or cadmium (10µM CdCl2). Cell growth
was monitored after 3 days. B, GFP without or with fusion of Pca1(250-350) or the
CL1 artificial degron were expressed in WT and Δdoa10 strains. Cells were cultured
in media with (+) or without (-) supplementation of cadmium (50µM CdCl2, 1hr). GFP
levels in total protein extracts were measured by Western blotting using anti-GFP
antibodies. Each blot was probed for phosphoglycerate kinase (PGK) to determine
equal loading.
4.4.5. Physical interaction between Pca1 and Doa10 via the N-terminal
degron. We hypothesized that the N-terminus of Pca1 functions as a Doa10 recognition
motif.

Pca1 and Doa10 interaction was determined by chemical crosslinking.

Microsomes were prepared from cells expressing thirteen c-myc epitope-tagged Doa10
(Doa10-myc) (19) and a fully functional HA-tagged Pca1 (HA-Pca1), or with deletion of
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the N-terminal regulatory domain (HA-Pca1Δ392) (6). Ste6* served as a positive control
for physical interaction between an ERAD substrate and Doa10 (19). Microsomes were
treated with dimethyl dithiobispropionimidate (DTBP), a thiol reversible and membrane
permeable cross-linker, and HA-tagged proteins were immunoprecipitated by anti-HA
conjugated sepharose beads. Doa10 was co-precipitated from cells expressing Pca1 or
Ste6* but not Pca1Δ392 which lacks the N-terminal degron (Fig. 4.5 first panel). This
data demonstrated that the N-terminus is required for either direct or indirect interaction
of Pca1 with Doa10.
4.4.6. Metal binding and conformational change of the Pca1 degron. Given
that cadmium or copper rescued Pca1 from degradation and that the Pca1 N-terminus
contains potential metal binding residues (6), we predicted that metal binding to this
region would mask a degradation signal. Since attempts to purify adequate amounts of
this protein have been a technical challenge, we utilized a (64Cu(II)) blotting assay (17) in
which HA-Pca1(250-350) was immunoprecipitated using anti-HA antibody conjugated
beads and transferred to a nitrocellulose membrane. Autoradiography of blots incubated
with
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Cu showed specific binding of radioactive copper to HA-Pca1(250-350) as no

signal was observed from bands corresponding to the same peptide in which all seven
cysteine residues were mutated to alanine (HA-Pca1(250-350)ΔCys) (Fig. 4.6A). Cu(II)
or Cd(II) but not Zn(II) effectively competed for
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Cu(II) binding implying that copper

and cadmium can compete for the same binding site(s) (Fig. 4.6B). Cd(II) appeared to
compete more effectively than copper at the same concentration (Fig. 4.6B), suggesting
higher
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Figure 4.5. The N-terminal regulatory domain is required for physical interaction
between Pca1 and Doa10. Expression constructs of HA-Pca1, Pca1 deleted of amino
acid residues 1-392 (HA-Pca1Δ392), or Ste6* (HA-Ste6*) were expressed in a strain
containing a chromosomal integration of 13 c-myc epitope tagged Doa10 (Doa10myc). Chemical cross-linking was performed using microsomes prepared from these
cells (See Materials and Methods). HA tagged proteins were immunoprecipitated (IP)
and denatured under reducing conditions to break crosslinking. Samples were
subjected to SDS-PAGE and Western blotting (W) using anti-myc antibodies (IP:HA,
W:myc), and then the same blot was stripped and re-probed with anti-HA antibodies
(IP:HA, W:HA). Total protein extracts were resolved on SDS-PAGE and analyzed by
Western blotting using anti-HA (W:HA) or anti-myc (W:myc) antibodies.

binding affinity. These metal binding specificities were in accordance with previously
observed cadmium and copper specific regulation of Pca1 stability (4).
To examine conformational changes associated with metal binding, we employed
a limited trypsin proteolysis assay of the Pca1 degron (HA-Pca1-(250-350)). Western
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4.5. Discussion
Our data supports a model (Fig. 4.7) illustrating an unanticipated regulatory
mechanism by which cells control the expression of a plasma membrane protein. In the
absence of cadmium, newly synthesized Pca1 is targeted for ERAD by an N-terminal
degron resulting in rapid turnover at the proteasome. Cadmium sensing by this degron
induces a conformational change, which prevents the recognition of Pca1 by the ERAD
machinery. Hence, cells are able to rapidly elevate Pca1 expression in response to
cadmium.
Given that cadmium is an extremely toxic metal of which environmental levels
fluctuate, the constant synthesis of a cadmium exporter would be advantageous for cell
survival. ERAD of Pca1 at the early step of synthesis keeps Pca1 levels at a minimum,
since expression is not necessary when cells are growing without cadmium stress. It is
also possible that Pca1 could play a role other than cadmium efflux, which would be
deleterious in the absence of cadmium. For instance, if Pca1 transports nutritional metal
ions due to low substrate specificity as shown for other P1B-type ATPases (31), the
constant degradation of Pca1 would prevent the loss of essential metals that are limiting
for growth.
ERAD eliminates misfolded or unassembled proteins, which is necessary for the
prevention of toxic accumulation of aberrant proteins (8, 9). At least 30% of newly
synthesized proteins are rapidly degraded by proteasomes (32). It has been suggested that
this observation represents the degradation of misfolded proteins and defective ribosomal
products resulting from errors in translation. This pool of peptides also provides both host
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and viral antigenic peptides to be displayed by MHC class I molecules (33). Our study
presented herein suggests another unexplored role for ERAD, which occurs in a degrondependent manner and would allow for fine tuning of secretory protein expression in
response to cellular cues.
Regulation of Pca1 expression at the ER may represent a conserved and largely
uncharacterized system by which cells control the expression levels of secretory proteins.
Consistent with this argument, molecular factors in the ERAD pathway are involved in
regulated destruction of proteins. Sterol metabolic status regulates ERAD of ER-resident
HMG-CoA reductase, the rate-limiting enzyme of sterol synthesis (34). Co-translational
degradation of apolipoprotein B at the ER is enhanced when lipid efflux from the liver is
not favored (35). In yeast, the Doa10 ubiquitin ligase also targets the cytoplasmic
MATα2 repressor for degradation in the absence of its MATa1 binding partner (36).
However, Pca1 is the first plasma membrane protein that is targeted to the ERAD
pathway by a degron in a substrate-dependent manner.
There is accumulating evidence suggesting expressional control of plasma
membrane transporters and ion channels early in the secretory pathway, although the
implication of ERAD in this process has not been firmly established. For instance, it was
shown that ubiquitination and proteasome-dependent degradation affects the expression
of a variety of cell surface proteins such as aquaporin (37), acetylcholine receptor (38),
ATP sensitive K+ channels (39), and opioid receptors (40). Intriguingly, under normal
conditions only 40% of newly synthesized human δ opioid receptors ever reach the cell
surface; however membrane-permeable opioid ligands facilitate maturation and ER
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export (41). It is of interest to determine whether this opioid dependent degradation of its
receptor occurs by a similar mechanism that we have established for Pca1.
It is unknown whether Doa10 directly recognizes the Pca1 degron or whether
other accessory factor(s) recruit Pca1 for ubiquitination. The requirement of the Pca1 Nterminus in the co-precipitation of Doa10 suggests a physical interaction between the
Pca1 degron and Doa10, although it is not certain yet whether this interaction is mediated
by other factor(s). In the case of Ste6*, cytosolic Hsp70 chaperones aid in this process
(19). However, our preliminary data did not indicate any significant role for Hsp70
chaperones in Pca1 ERAD.
The recognition determinants of the Pca1 degron and that of other ERAD
substrates remain unknown. The current hypothesis is that misfolded proteins display
normally buried hydrophobic residues to the cytosolic surface, which serves as a
targeting signal for degradation. The Deg1 degron of MATα2 repressor is predicted to
form an amphipathic helix of which hydrophobic residues are crucial for its instability
(36). However, there is no obvious similarity in the primary sequence of Deg1 and the
Pca1 degron. Our preliminary mutagenesis studies have revealed that single amino acid
substitutions of hydrophobic residues hinder ERAD recognition of the Pca1 degron.
These observations suggest that specific characteristics within this degron are recognized
by the ERAD machinery rather than a general misfolded structure as has been postulated
for other ERAD substrates. Structural characterization of the Pca1 metal sensing degron
in apo and metal-bound forms would define what features attract the ERAD machinery.
This study would also provide useful information for the identification of other proteins
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that may possess a similar type of degradation signal. While the Pca1 degron does not
have significant sequence identity with known proteins, we could identify potential metal
binding cysteine and histidine-rich extensions in predicted Pca1 family members of
plants (31) and fungi. We are currently testing whether expression of these proteins or if
other proteins in yeast, plants and mammals are also regulated by ERAD.
The identification of the molecular factors involved in Pca1 turnover reveals a
novel regulatory mechanism by which yeast cells selectively control the expression of a
plasma membrane protein at an early step of synthesis. Small molecules, including
substrates or metabolites, or signaling pathways may actively regulate protein secretion at
the ER in a target specific manner as demonstrated for Pca1.

Figure 4. 7 Model of cadmium-regulated expression of Pca1. Cadmium sensing
occurs at the ER by metal binding to the cytosolic N-terminal domain of Pca1
followed by conformational changes which prevents recognition for ubiquitination by
ERAD factors, including Cue1, Ubc7, and Doa10. Pca1 extraction from the ER is
facilitated by Cdc48 after ubiquitination. Black squares indicate Pca1 trans-membrane
domains. Black arrow indicates cadmium efflux via Pca1 at the plasma membrane.
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Chapter 5
Significance and Future Directions
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5.1.

Identification of a New Metal-transporting P-type ATPase
Cadmium is a serious environmental contaminant implicated in various disorders.

Human exposure to cadmium is unavoidable and widespread. In the context of these
public health concerns, understanding the mechanisms of heavy metal metabolism
represents an important research avenue. Pca1 represents the first cadmium-specific
efflux system. Knowledge gained from this study may lead to the development of new
strategies for prevention and treatment of cadmium related disorders.
P1B-type ATPases are divided into different subclasses based on structural
features and substrate specificity. Sequence alignments which have identified conserved
metal binding residues have been used to predict substrate specificity, although the
structural determinants of substrate specificity for P1B-type ATPases have not been firmly
established. According to these criteria, Pca1 is currently classified as a copper (I)
translocating P1B-type ATPase; however, functional characterization of Pca1 supports
cadmium selectivity. Given that all known cadmium translocating P1B-type ATPases in
plants and bacteria also transport other divalent heavy metals (e.g. zinc (II), lead (II),
cobalt (II), mercury (II) ), Pca1 appears to be a new P1B-type ATPase subtype. Since, a
mechanistic understanding of the determinants of substrate specificity are lacking, Pca1
will be an important tool for understanding ion selectivity of P1B-type ATPases.
Our BLAST searches have revealed several potential Pca1 homologues from
fungi that have high sequence identity and similarity with Pca1 (Figure 5.1). Cloning and
functional characterization of these genes would establish a new cadmium-specific
subtype of a P1B-type ATPase
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It does not appear that a cadmium-transporting P1B-type ATPase exists in the
human genome in addition to copper-transporting ATP7a and ATP7b. However, several
lines of evidence suggest that mammals possess cadmium export mechanism(s).
Identification of cadmium exporters in humans would lead to better understanding of the
mechanisms of cadmium detoxification and open up a new research avenue for
combating cadmium-related disorders.

Organism
G .zea
P .janthinellum
A. fumigatus
A.clavatus
C. immitus
B.fuckeliana

% identity
45.0
45.6
43.0
42.4
33.7
33.5

% similarity
62.5
60.9
59.8
58.5
51.8
46.9

Figure 5.1. Sequence comparisons and phylogenetic tree of possible functional
homologues of Pca1 from other fungi. Protein sequences were retrieved from the NCBI
data base. Alignments were produced by Clustal W.
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5.2. Genetic Variations in Molecular Factors Involved in Cadmium Detoxification
Sequence comparisons of Pca1 revealed a missense mutation in a critical residue,
which leads to a non-functional Pca1 allele. This mutation exists in several laboratory
strains but not in natural isolates. The most plausible explanation is that the ancestral
strain harboring the G970R mutation was propagated to research laboratories across the
world. The non-functional Pca1 allele at least in part explains the cadmium
hypersensitivity of laboratory yeast strains compared to natural strains. It is interesting to
note that a natural strain deleted of Pca1 was still more resistant to cadmium than a
laboratory yeast strain (unpublished data), which suggests that other cadmium resistance
factors remain to be discovered. Metal concentrations in the environment are variable and
can rapidly fluctuate, imposing a strong selection pressure for cadmium defense genes.
Population bottlenecks and decreased selection pressure in a laboratory environment have
likely resulted in the accumulation of deleterious mutations in genes involved in
cadmium resistance. The genetic variation of cadmium resistance among yeast strains
provides an interesting research model to identify new cadmium resistance genes and
explore gene-environment interactions associated with evolution.
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5.3.

A Novel Mode of Expressional Control of a Plasma Membrane Protein
For the first time, our work has definitively demonstrated that the expression

levels of a plasma membrane protein can be regulated at the ER in response to cellular
needs. Importantly, we have also isolated a specific response element and have offered a
mechanistic explanation for ligand dependent masking of an ERAD signal. Several layers
of evidence have been presented which support these claims. First, Pca1 is rapidly
degraded via the ubiquitination-proteasome pathway; however in the presence of its
cadmium substrate, ubiquitination is inhibited, resulting in Pca1 stabilization. Second,
Pca1 degradation requires components of the ERAD pathway, including ER resident E2
and E3 ubiquitin ligases. Third, cysteine dependent metal binding to the Pca1(250-350)
domain result in conformational changes, which is believed to be a mechanism of
degradation signal masking.
It is of interest to determine whether any other cell surface proteins are regulated
at the ER in a similar manner as has been demonstrated for Pca1. Indeed, the ubiquitin
proteasome system has been implicated in modulation of a variety of cell surface proteins
including, aquaporin (1), ACh receptor (2), ATP sensitive K+ channels (3), and opioid
receptors (4). Intriguingly, under normal conditions only 40% of newly synthesized
human δ opioid receptors ever reach the cell surface. However, membrane-permeable
opioid ligands can facilitate their maturation and ER export (5). Ligand and/or cellular
signal-dependent escape of ERAD by secretory proteins may be a prevalent but
uncharacterized regulatory mechanism determining protein expression levels in response
to cellular needs.
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5.4.

A New Protein Degradation Signal
A fundamental question that remains unanswered is whether the mode of Pca1

regulation and its degradation signal are conserved in other P1B-type ATPases or other
unrelated proteins. Sequence alignments of the degradation signal motif in Pca1 with
close homologues in fungi have revealed a consensus sequence (Figure 5.2).
Interestingly, cysteine residues implicated in copper or cadmium binding are completely
conserved. Selective mutagenesis of other conserved residues and cloning and
characterization of these Pca1 homologues will determine if cadmium-regulated ERAD is
conserved among these proteins.

Figure 5.2. Determinants of the Pca1 Degron. (A) Sequence alignment of the
Pca1(250-350) domain with putative Pca1 homologues. Cysteine residues previously
implicated in metal binding are highlighted. Arrow indicates P314 and F318. (B)
Confocal fluorescent microscopy of GFP-Pca1 or mutant alleles expressed in a wild-type
yeast strain.
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5.5. Does the ERAD Machinery Recognize a Specific Signal Rather Than General
Misfolding?
The structural features of ERAD substrates and how they are recognized for
delivery to the ER degradation machinery remain unknown. The current hypothesis is
that degrons display characteristics of misfolded proteins in which normally buried
hydrophobic residues are exposed to the cytosolic surface. Due to a lack of structural
data, the only insight into the degradation requirements of a natural degron come from
mutational analysis of the Deg1 signal identified from yeast MATα repressor. A similar
approach will identify key determinants for recognition of the Pca1 degron. Our
preliminary mutagenesis studies have identified key bulky hydrophobic residues (P314
and F318) that are major determinants of the Pca1 degron (Figure 5.2). Although these
residues do not appear to be conserved, they are in close proximity to the C311 and C312
residues which were previously implicated in cadmium binding (Chapter 3). Ultimately,
structural characterization of the Pca1 metal sensing degron in apo and metal-bound
forms would, for the first time, define what features constitute an ERAD signal and how
they can be masked by ligand binding.
It is unknown whether the Doa10 E3 ligase directly recognizes the Pca1 degron or
whether other accessory factor(s) recruit Pca1 for ubiquitination. There is some evidence
that cytosolic Hsp70 chaperones aid in this process, as is the case for Ste6* (6). However,
our preliminary data do not indicate any significant role for Hsp70 chaperones in Pca1
ERAD (unpublished observations). The requirement for the Pca1 N-terminus in the coimmunoprecipitation of Doa10 suggests an interaction between the Pca1 degron and
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Doa10. However, it is not certain yet whether this interaction is mediated by other
factor(s). Pull down of interacting proteins followed by tandem MS/MS peptide
sequencing would be a strategy for identification of these factors.
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5.6.

Broad Impact of this Study in Biology and Medicine
The unanticipated discovery of Pca1 regulation by ERAD has significant

implications in understanding cellular regulatory mechanisms of protein expression. For
some time it has been known that a large fraction of newly synthesized proteins is rapidly
degraded by proteasomes (7). The current view is that this observation most likely
represents the degradation of misfolded proteins and defective ribosomal products that
result from errors in translation. It is becoming increasingly evident, especially after the
elucidation of Pca1 regulation at the ER, that the degradation of such a large pool of
newly synthesized proteins may be part of a regulatory process. This mode of regulation
allows cells to rapidly respond to cellular cues. Ligand binding and/or post-translational
regulation

(e.g.,

phosphorylation,

protein-protein

interactions)

followed

by

conformational masking of ERAD signals may be a common but largely uncharacterized
cellular phenomenon. Perhaps a large portion of the secretory proteome is regulated in
this manner. Characterization of conserved features in degrons like those found in the Nterminal domain of Pca1 could lead to the identification of other proteins in which ERAD
plays a regulatory role in protein expression. Structural characterization of these degrons
may make it one day possible to design small molecules to control the expression or
degradation of a select protein through the ERAD pathway as a therapeutic strategy.
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